Filed Pursuant to Rule 424(b)(3)
File No. 333-157075
AEROFLEX INCORPORATED
SUPPLEMENT NO. 3 TO
MARKET MAKING PROSPECTUS DATED
FEBRUARY 11, 2009
THE DATE OF THIS SUPPLEMENT IS JUNE 5, 2009
On May 14, 2009, Aeroflex Incorporated filed the attached Quarterly Report on Form 10-Q.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________________
FORM 10-Q
__________________
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended | March 31, 2009 |
Commission File Number 000-02324
__________________________
AEROFLEX INCORPORATED
(Exact name of Registrant as specified in its Charter)
DELAWARE | 11-1974412 |
(State or other jurisdiction | (I.R.S. Employer |
of incorporation or organization) | Identification No.) |
35 South Service Road | |
P.O. Box 6022 | |
Plainview, N.Y. | 11803-0622 |
(Address of principal executive offices) | (Zip Code) |
(516) 694-6700
(Registrant’s telephone number, including area code)
________________________________________________
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulations S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes ¨ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer ¨ | Accelerated filer¨ | |
Non-accelerated filer x | Smaller reporting company ¨ | |
(Do not check if a smaller reporting company) |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨ No x
Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.
May 14, 2009 | 1,000 |
(Date) | (Number of Shares) |
AEROFLEX INCORPORATED
AND SUBSIDIARIES
INDEX
PAGE | |||
PART 1: FINANCIAL INFORMATION | |||
Item 1 | UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS | ||
March 31, 2009 and June 30, 2008 | 2 | ||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||
Three Months Ended March 31, 2009 and 2008 | |||
Nine Months Ended March 31, 2009 and | |||
Periods from July 1, 2007 to August 14, 2007 | |||
and August 15, 2007 to March 31, 2008 | 3 – 4 | ||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||
Nine Months Ended March 31, 2009 and | |||
Periods from July 1, 2007 to August 14, 2007 | |||
and August 15, 2007 to March 31, 2008 | 5 | ||
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS | 6 – 38 | ||
Item 2 | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND | ||
RESULTS OF OPERATIONS | |||
Three and Nine Months Ended March 31, 2009 and 2008 | 39 – 53 | ||
Item 3 | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK | 53 | |
Item 4T | CONTROLS AND PROCEDURES | 53 | |
PART II: OTHER INFORMATION | |||
Item 1 | LEGAL PROCEEDINGS | 54 | |
Item 1A | RISK FACTORS | 55 | |
Item 2 | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS | 55 | |
Item 3 | DEFAULTS UPON SENIOR SECURITIES | 55 | |
Item 4 | SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS | 55 | |
Item 5 | OTHER INFORMATION | 56 | |
Item 6 | EXHIBITS | 56 | |
SIGNATURES | 57 | ||
EXHIBIT INDEX | 58 | ||
CERTIFICATIONS | 59 – 63 |
- 1 - -
Aeroflex Incorporated
and Subsidiaries
Unaudited Condensed Consolidated Balance Sheets
(In thousands, except share and per share data )
March 31, | June 30, | |||||||
2009 | 2008 | |||||||
Successor Entity | Successor Entity | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 53,931 | $ | 54,149 | ||||
Accounts receivable, less allowance for doubtful accounts of $3,059 and $2,683 | 113,468 | 147,983 | ||||||
Inventories | 137,854 | 134,891 | ||||||
Deferred income taxes | 25,736 | 27,039 | ||||||
Prepaid expenses and other current assets | 10,897 | 12,184 | ||||||
Total current assets | 341,886 | 376,246 | ||||||
Property, plant and equipment, net | 98,173 | 104,649 | ||||||
Non-current marketable securities | 17,523 | 19,960 | ||||||
Deferred financing costs, net | 26,947 | 30,185 | ||||||
Other assets | 15,611 | 18,560 | ||||||
Intangible assets with definite lives, net | 298,594 | 344,866 | ||||||
Intangible assets with indefinite lives | 113,665 | 123,378 | ||||||
Goodwill | 454,252 | 461,155 | ||||||
Total assets | $ | 1,366,651 | $ | 1,478,999 | ||||
Liabilities and Stockholder's Equity | ||||||||
Current liabilities: | ||||||||
Current portion of long-term debt | $ | 5,383 | $ | 5,574 | ||||
Accounts payable | 36,811 | 39,382 | ||||||
Advance payments by customers and deferred revenue | 32,731 | 27,144 | ||||||
Income taxes payable | 11,373 | 1,936 | ||||||
Accrued payroll expenses | 20,979 | 24,525 | ||||||
Accrued expenses and other current liabilities | 34,359 | 56,830 | ||||||
Total current liabilities | 141,636 | 155,391 | ||||||
Long-term debt | 881,213 | 873,237 | ||||||
Deferred income taxes | 123,448 | 159,457 | ||||||
Defined benefit plan obligations | 6,043 | 6,263 | ||||||
Other long-term liabilities | 23,314 | 8,003 | ||||||
Total liabilities | 1,175,654 | 1,202,351 | ||||||
Stockholder's equity: | ||||||||
Common stock, par value $.10 per share; authorized 1,000 shares; issued and outstanding 1,000 shares | - | - | ||||||
Additional paid-in capital | 396,018 | 381,666 | ||||||
Accumulated other comprehensive income (loss) | (74,858 | ) | 407 | |||||
Accumulated deficit | (130,163 | ) | (105,425 | ) | ||||
Total stockholder's equity | 190,997 | 276,648 | ||||||
Total liabilities and stockholder's equity | $ | 1,366,651 | $ | 1,478,999 |
See notes to unaudited condensed consolidated financial statements.
- 2 - -
Aeroflex Incorporated and Subsidiaries
Unaudited Condensed Consolidated Statements of Operations
(In thousands)
Three Months Ended March 31, | ||||||||
2009 | 2008 | |||||||
Successor Entity | Successor Entity | |||||||
Net sales | $ | 139,439 | $ | 157,304 | ||||
Cost of sales | 72,834 | 88,068 | ||||||
Gross profit | 66,605 | 69,236 | ||||||
Selling, general and administrative costs | 30,954 | 32,194 | ||||||
Research and development costs | 17,941 | 18,154 | ||||||
Amortization of acquired intangibles | 14,956 | 20,872 | ||||||
Acquired in-process research and development costs | 2,291 | - | ||||||
Company sale transaction expenses | - | 850 | ||||||
66,142 | 72,070 | |||||||
Operating income (loss) | 463 | (2,834 | ) | |||||
Other income (expense) | ||||||||
Interest expense | (20,566 | ) | (20,536 | ) | ||||
Other income (expense), net | (47 | ) | 1,960 | |||||
Total other income (expense) | (20,613 | ) | (18,576 | ) | ||||
Income (loss) from continuing operations before income taxes | (20,150 | ) | (21,410 | ) | ||||
Provision (benefit) for income taxes | (6,416 | ) | (5,973 | ) | ||||
Income (loss) from continuing operations | (13,734 | ) | (15,437 | ) | ||||
Income (loss) from discontinued operations, net of taxes | - | (968 | ) | |||||
Net income (loss) | $ | (13,734 | ) | $ | (16,405 | ) |
See notes to unaudited condensed consolidated financial statements.
- 3 - -
Aeroflex Incorporated and Subsidiaries
Unaudited Condensed Consolidated Statements of Operations
(In thousands)
Nine Months Ended | August 15, 2007 | July 1, 2007 | ||||||||||
March 31, 2009 | to March 31, 2008 | to August 14, 2007 | ||||||||||
Successor Entity | Successor Entity | Predecessor Entity | ||||||||||
Net sales | $ | 437,099 | $ | 420,076 | $ | 38,221 | ||||||
Cost of sales | 229,976 | 258,952 | 22,861 | |||||||||
Gross profit | 207,123 | 161,124 | 15,360 | |||||||||
Selling, general and administrative costs | 96,612 | 84,150 | 19,031 | |||||||||
Research and development costs | 52,045 | 48,556 | 12,178 | |||||||||
Amortization of acquired intangibles | 47,546 | 52,281 | 1,692 | |||||||||
Acquired in-process research and development costs | 2,291 | 24,340 | - | |||||||||
Company sale transaction expenses | - | 32,459 | 3,717 | |||||||||
198,494 | 241,786 | 36,618 | ||||||||||
Operating income (loss) | 8,629 | (80,662 | ) | (21,258 | ) | |||||||
Other income (expense) | ||||||||||||
Interest expense | (63,031 | ) | (53,649 | ) | (275 | ) | ||||||
Other income (expense), net | 12,366 | 3,881 | 294 | |||||||||
Total other income (expense) | (50,665 | ) | (49,768 | ) | 19 | |||||||
Income (loss) from continuing operations before income taxes | (42,036 | ) | (130,430 | ) | (21,239 | ) | ||||||
Provision (benefit) for income taxes | (17,298 | ) | (36,389 | ) | (6,831 | ) | ||||||
Income (loss) from continuing operations | (24,738 | ) | (94,041 | ) | (14,408 | ) | ||||||
Income (loss) from discontinued operations, net of taxes | - | (2,457 | ) | (2,508 | ) | |||||||
Net income (loss) | $ | (24,738 | ) | $ | (96,498 | ) | $ | (16,916 | ) |
See notes to unaudited condensed consolidated financial statements.
- 4 - -
Aeroflex Incorporated
and Subsidiaries
Unaudited Condensed Consolidated Statements of Cash Flows
(In thousands)
Nine Months Ended | August 15, 2007 | July 1, 2007 | ||||||||||
March 31, | to March 31, | to August 14, | ||||||||||
2009 | 2008 | 2007 | ||||||||||
Successor Entity | Successor Entity | Predecessor Entity | ||||||||||
Cash flows from operating activities: | ||||||||||||
Net income (loss) | $ | (24,738 | ) | $ | (96,498 | ) | $ | (16,916 | ) | |||
Loss from discontinued operations, net of taxes | - | 2,457 | 2,508 | |||||||||
Income (loss) from continuing operations | (24,738 | ) | (94,041 | ) | (14,408 | ) | ||||||
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||||||||||||
Depreciation and amortization | 63,659 | 66,465 | 3,662 | |||||||||
Acquired in-process research and development costs | 2,291 | 24,340 | - | |||||||||
Acquisition related adjustment to cost of sales | - | 38,968 | - | |||||||||
Acquisition related adjustment to sales | 240 | 2,235 | - | |||||||||
Deferred income taxes | (27,851 | ) | (38,751 | ) | 5,284 | |||||||
Non - cash share based compensation | 1,466 | 2,634 | 214 | |||||||||
Amortization of deferred financing costs | 3,579 | 2,812 | 217 | |||||||||
Paid in kind interest | 11,913 | 7,605 | - | |||||||||
Excess tax benefits from share based compensation arrangements | - | - | (12,542 | ) | ||||||||
Other, net | 729 | 651 | (24 | ) | ||||||||
Change in operating assets and liabilities, net of effects from purchases of businesses: | ||||||||||||
Decrease (increase) in accounts receivable | 21,185 | (30,689 | ) | 47,889 | ||||||||
Decrease (increase) in inventories | (14,451 | ) | 8,008 | (12,885 | ) | |||||||
Decrease (increase) in prepaid expenses and other assets | 2,253 | 24 | (26,899 | ) | ||||||||
Increase (decrease) in accounts payable, accrued expenses and other liabilities | (5,282 | ) | (16,948 | ) | 21,246 | |||||||
Net cash provided by (used in) continuing operations | 34,993 | (26,687 | ) | 11,754 | ||||||||
Net cash provided by (used in) discontinued operations | - | (3,133 | ) | (461 | ) | |||||||
Net cash provided by (used in) operating activities | 34,993 | (29,820 | ) | 11,293 | ||||||||
Cash flows from investing activities: | ||||||||||||
Acquisition of Predecessor Entity, net of cash acquired | - | (1,118,293 | ) | - | ||||||||
Payments for purchase of businesses, net of cash acquired | (7,832 | ) | 1,522 | - | ||||||||
Capital expenditures | (12,958 | ) | (8,528 | ) | (1,088 | ) | ||||||
Proceeds from the sale of property, plant and equipment | 1,359 | 30 | - | |||||||||
Purchase of marketable securities | - | (631,805 | ) | (53,828 | ) | |||||||
Proceeds from sale of marketable securities | - | 599,977 | 63,328 | |||||||||
Other | (4 | ) | - | - | ||||||||
Net cash provided by (used in) investing activities by continuing operations | (19,435 | ) | (1,157,097 | ) | 8,412 | |||||||
Net cash provided by (used in) discontinued operations | - | (32 | ) | (6 | ) | |||||||
Net cash provided by (used in) investing activities | (19,435 | ) | (1,157,129 | ) | 8,406 | |||||||
Cash flows from financing activities: | ||||||||||||
Proceeds from issuance of common stock | - | 378,350 | - | |||||||||
Borrowings under debt agreements | - | 870,000 | - | |||||||||
Debt repayments | (4,129 | ) | (4,453 | ) | (29 | ) | ||||||
Debt financing costs | (340 | ) | (27,436 | ) | (477 | ) | ||||||
Excess tax benefits from share based compensation arrangements | - | - | 12,542 | |||||||||
Proceeds from the exercise of stock options and warrants | - | - | 583 | |||||||||
Amounts paid for withholding taxes on stock option exercises | - | (14,142 | ) | (56 | ) | |||||||
Withholding taxes collected for stock option exercises | - | 14,142 | 56 | |||||||||
Net cash provided by (used in) financing activities | (4,469 | ) | 1,216,461 | 12,619 | ||||||||
Effect of exchange rate changes on cash and cash equivalents | (11,307 | ) | (2,305 | ) | 178 | |||||||
Net increase (decrease) in cash and cash equivalents | (218 | ) | 27,207 | 32,496 | ||||||||
Cash and cash equivalents at beginning of period | 54,149 | - | 13,000 | |||||||||
Cash and cash equivalents at end of period | $ | 53,931 | $ | 27,207 | $ | 45,496 |
See notes to unaudited condensed consolidated financial statements.
- 5 - -
AEROFLEX INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. | Basis of Presentation |
The condensed consolidated financial statements of Aeroflex Incorporated and Subsidiaries (the “Company”, “we”, or “our’’) presented herein are unaudited. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly our financial position, results of operations and cash flows as of and for all periods presented have been made. Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been omitted. These condensed consolidated financial statements should be read in conjunction with the Company’s June 30, 2008 audited financial statements and notes thereto.
Results of operations for the three and nine months ended March 31, 2009 are not necessarily indicative of results of operations for future interim periods or for the full fiscal year ending June 30, 2009.
The Company and its Sale
We design, engineer and manufacture microelectronics and test solution and measurement equipment that are sold primarily to the broadband communications, aerospace and defense markets. Our fiscal year ends on June 30.
On August 15, 2007, the Company was acquired by affiliates of or funds managed by The Veritas Capital Fund Ill, L.P. (“Veritas”), Golden Gate Private Equity, Inc. (“Golden Gate”) and GS Direct, L.L.C. (“GS Direct”) and certain members of management (“the Merger”) (see Note 3).
Presentation and Use of Estimates
Our financial statements are prepared in conformity with U.S. GAAP. We consolidate our subsidiaries, all of which, except for Test Evolution Corporation (see Note 4), are wholly owned. All significant intercompany balances and transactions have been eliminated.
The condensed consolidated financial statements presented as of March 31, 2009 and June 30, 2008, and for the three months ended March 31, 2009 and 2008, the nine months ended March 31, 2009 and the period from August 15, 2007 to March 31, 2008 represent the Company subsequent to the Merger (the “Successor” or “Successor Entity”), whereas the condensed consolidated financial statements for the period from July 1, 2007 to August 14, 2007 represent the Company prior to the Merger (the “Predecessor” or “Predecessor Entity”). The purchase method of accounting was applied effective August 15, 2007 in connection with the Merger. Therefore, our condensed consolidated financial statements for periods before August 15, 2007 are presented on a different basis than those for the periods after August 14, 2007 and, as such, are not comparable.
The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires that management of the Company make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Among the more significant estimates included in our consolidated financial statements are revenue and cost recognition under long-term contracts; the valuation of accounts receivable, inventories, investments and deferred tax assets; the depreciable lives of fixed assets and useful lives of amortizable intangible assets; the valuation of assets acquired and liabilities assumed in business combinations; the recoverability of long-lived amortizable intangible assets and goodwill; share-based compensation; restructuring charges; asset retirement obligations and certain accrued expenses and contingencies.
- 6 - -
We are subject to uncertainties such as the impact of future events, economic, environmental and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. The accounting estimates used in the preparation of our consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as our operating environment changes. Changes in estimates are made when circumstances warrant them. Such changes and refinements in estimation methodologies are reflected in reported results of operations. If material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements.
Cash and Cash Equivalents
All highly liquid investments having maturities of three months or less at the date of acquisition are considered to be cash equivalents.
Marketable Securities
Marketable securities are classified as available-for-sale and are recorded at fair value with unrealized gains and losses reported as a separate component of stockholder’s equity. Realized gains and losses and declines in market value judged to be other than temporary, of which there were none, are included in other income (expense). Interest income is also included in other income.
At March 31, 2009, our marketable securities consisted of $17.5 million of auction rate securities, which is net of a $2.4 million valuation allowance. Auction rate securities represent long-term (generally maturities of ten years to thirty-five years from the date of issuance) variable rate bonds tied to short-term interest rates that are reset through an auction process, which occurs every seven to thirty-five days, and are classified as available for sale securities. All but one (with the one security having a carrying value of $1.6 million and an A rating) of our auction rate securities retain a triple-A rating by at least one nationally recognized statistical rating organization. In addition, certain of our auction rate securities are backed by student loans whose principal and interest are federally guaranteed by the Family Federal Education Loan Program. Through March 31, 2009, we have collected all interest payments on all our auction rate securities when due, and since early February 2008 (when auctions began to fail) have redeemed $26.5 million of auction rate securities at par.
At March 31, 2009, the par value of our auction rate securities was $19.9 million; however we have estimated that the fair value of our auction rate securities as of that date was $17.5 million. Since many auctions are failing and given that there is currently no active secondary market for our investment in auction rate securities, the determination of fair value was based on the following factors:
· | continuing illiquidity; |
· | lack of action by the issuers to establish different forms of financing to replace or redeem these securities; and |
· | the credit quality of the underlying securities. |
As fair values have continued to be below cost, we have considered various factors in determining whether to recognize an other than temporary impairment charge, including the length of time and the extent to which the fair value has been below the cost basis, the current financial condition of the issuer and our intent and ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in market value.
Auction rate securities are classified as non-current assets in the accompanying March 31, 2009 and June 30, 2008 consolidated balance sheets.
- 7 - -
Inventories
Inventories, including amounts related to long-term contracts accounted for under percentage-of-completion accounting, are stated at the lower of cost (first-in, first-out) or market.
Financial Instruments and Derivatives
Foreign currency contracts are used in certain circumstances to protect us from fluctuations in exchange rates. We enter into foreign currency contracts, which are not designated as hedges. Thus the change in fair value is included in income as it occurs, within other income (expense).
Our interest rate swap derivatives are designated as cash flow hedges. As such, they are recorded on the balance sheet as assets or liabilities at their fair value, with changes in the fair value of such derivatives, net of taxes, recorded as a component of other comprehensive income.
See Note 8 for more details.
Revenue Recognition
We recognize revenue when persuasive evidence of an arrangement exists, the selling price is fixed or determinable, and collectability of the resulting receivable is reasonably assured.
For arrangements other than certain long-term contracts, revenue (including shipping and handling fees) is recognized when products are shipped and title has passed to the customer. If title does not pass until the product reaches the customer’s delivery site, recognition of the revenue is deferred until that time. Certain of our sales are to distributors which have a right to return some portion of product within up to eighteen months of sale. We recognize revenue on these sales at the time of shipment to the distributor as the returns under these arrangements have been insignificant and can be reasonably estimated. A provision for such estimated returns is recorded at the time sales are recognized.
Long-term contracts are accounted for in accordance with SOP 81-1 “Accounting for Performance of Construction-Type and Certain Production-Type Contracts.” We determine estimated contract profit rates and use the percentage-of-completion method to recognize revenues and associated costs as work progresses on certain long-term contracts. We measure the extent of progress toward completion generally based upon one of the following methods (based upon an assessment of which method most closely aligns to the underlying earnings process): (i) the units-of-delivery method, (ii) the cost-to-cost method, using the ratio of contract costs incurred as a percentage of total estimated costs at contract completion (based upon engineering and production estimates), or (iii) the achievement of contractual milestones. Provisions for anticipated losses or revisions in estimated profits on contracts-in-process are recorded in the period in which such anticipated losses or revisions become evident.
Revenue from sales of products where software is other than incidental to their performance, including related software support and maintenance contracts is recognized in accordance with SOP 97-2, “Software Revenue Recognition.” Accordingly, revenue for software is recognized when the software is delivered, if all of the above criteria for revenue recognition are met.
When a customer purchases software together with post contract support, we allocate a portion of the fee to the post contract support for its fair value based on the contractual renewal rate or the amount the support is sold for on a standalone basis. Post contract support fees are deferred in Advance Payments by Customers and Deferred Revenue, and recognized as revenue ratably over the term of the related contract.
- 8 - -
Acquisition Accounting
We use the purchase method to account for business combinations, whereby the total cost of an acquisition is allocated to the tangible and intangible assets acquired and liabilities assumed based upon their respective fair values at the date of acquisition. The allocation of the purchase price is dependent upon certain valuations and other studies, which contain estimates and assumptions.
Long-Lived Assets
We test goodwill annually for impairment and whenever events or circumstances indicate impairment might have occurred. We evaluate the recoverability of goodwill using a two-step impairment test approach at the reporting unit level. In the first step, which is used to identify potential impairments, the overall fair value for the reporting unit is compared to its carrying amount including goodwill. If the fair value of a reporting unit is less than the carrying amount, a second step is performed which compares the implied fair value of the reporting unit’s goodwill to the carrying amount of the goodwill. The implied fair value for the goodwill is determined based on the difference between the fair value of the reporting unit and the fair value of its net identifiable assets. If the implied fair value of the goodwill is less than its carrying amount, the difference is recognized as an impairment.
Our amortizable intangible assets, which are comprised primarily of developed technology and customer related intangibles, are subject to amortization over periods ranging up to 11 years, on a straight-line basis. Property, plant and equipment are stated at cost. Depreciation of plant and equipment is provided over the estimated useful lives of the respective assets, principally on a straight-line basis. Leasehold improvements are amortized over the life of the lease, including anticipated renewals, or the estimated life of the asset, whichever is shorter.
We periodically review our depreciable and amortizable long-lived assets for impairment whenever events or circumstances indicate that the carrying amount of an asset may not be recoverable. If the sum of the expected undiscounted cash flows is less than the carrying amount of the asset, an impairment loss is recognized as the amount by which the carrying amount of the asset exceeds its fair value.
Research and Development Costs
We charge all research and development costs to expense as incurred, except those of our software products for which costs incurred between the date of product technological feasibility and the date that the software is available for general release are capitalized. We use a working model of the software or a detailed program design to assess technological feasibility. There were software development costs capitalized of $0 and $437,000 for the three months ended March 31, 2009 and 2008, respectively, and $437,000 and $0 for the periods from August 15, 2007 to March 31, 2008 and July 1, 2007 to August 14, 2007, respectively. Approximately $209,000 of software development costs were capitalized during the nine months ended March 31, 2009. Capitalized software development costs are amortized to cost of sales based on the higher of a) the percentage of revenue for units delivered to total anticipated revenue for the related product, or b) on a straight-line basis. Capitalized software development costs of $331,000 and $1.2 million were included in Other Assets at March 31, 2009 and June 30, 2008, respectively.
Income Taxes
We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be realized or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
- 9 - -
Foreign Currency Translations
The financial statements of our foreign subsidiaries are measured in their local currency and then translated into U.S. dollars using the current rate method. Under the current rate method, assets and liabilities are translated using the exchange rate at the balance sheet date. Revenues and expenses are translated at average exchange rates prevailing throughout the year.
Gains and losses resulting from the translation of financial statements of foreign subsidiaries are accumulated in other comprehensive income (loss) and presented as part of stockholder’s equity. Realized and unrealized foreign currency exchange gains (losses) from the settlement of foreign currency transactions are reflected in other income (expense) and amounted to $(669,000) and $820,000 for the three months ended March 31, 2009 and 2008, respectively, and $10.5 million, $1.8 million and $193,000 for the nine months ended March 31, 2009 and the periods from August 15, 2007 to March 31, 2008 and July 1, 2007 to August 14, 2007, respectively.
Comprehensive Income
Comprehensive income consists of net income (loss) and equity adjustments relating to foreign currency translation, changes in fair value of certain derivatives and non-current marketable securities and adjustments to the minimum pension liability.
Recently Adopted Accounting Pronouncements
In September 2006, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards (“SFAS”) 157, “Fair Value Measurements,” to clarify the definition of fair value, establish a framework for measuring fair value and expand the disclosures on fair value measurements. SFAS 157 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). SFAS 157 also stipulates that, as a market-based measurement, fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability, and establishes a fair value hierarchy that distinguishes between (a) market participant assumptions developed based on market data obtained from sources independent of the reporting entity (observable inputs) and (b) the reporting entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).
In February 2008, the FASB issued FASB Staff Position (“FSP”) No. FAS 157-1, “Application of FASB Statement No. 157 to FASB Statement No. 13 and Other Accounting Pronouncements That Address Fair Value Measurements for Purposes of Lease Classification or Measurement under Statement 13.” This FSP amends SFAS 157 to exclude certain leasing transactions accounted for under previously existing accounting guidance. However, this scope exception does not apply to assets acquired and liabilities assumed in a business combination, regardless of whether those assets and liabilities are related to leases.
In February 2008, the FASB issued FSP No. FAS 157-2, “Effective Date for FASB Statement No. 157.” This FSP permits the delayed application of SFAS 157 for nonfinancial assets and nonfinancial liabilities, as defined in this FSP, except for those that are recognized or disclosed at fair value in the financial statements at least annually, until the beginning of our fiscal 2010. As of July 1, 2008, we adopted SFAS 157 (see Note 9), with the exception of its application to nonfinancial assets and nonfinancial liabilities, which we will defer in accordance with FSP No. FAS 157-2. We are currently evaluating the impact on our consolidated financial statements of adopting SFAS 157 at the beginning of fiscal 2010 for such nonfinancial assets and nonfinancial liabilities.
- 10 - -
In October 2008, the FASB issued FSP FAS 157-3, “Determining the Fair Value of a Financial Asset When the Market for That Asset Is Not Active,” which clarifies the application of SFAS 157 in a market that is not active and provides an example to illustrate key considerations in determining the fair value of a financial asset when the market for that financial asset is not active. The FSP was effective upon issuance, including prior periods for which financial statements were not issued. Revisions resulting from a change in the valuation technique or its application will be accounted for as a change in accounting estimate following the guidance in SFAS 154, “Accounting Changes and Error Corrections.” However, the disclosure provisions in SFAS 154 for a change in accounting estimate are not required for revisions resulting from a change in valuation technique or its application. We adopted SFAS 157 and FSP FAS 157-3 beginning in our fiscal 2009 first quarter (see Note 9). As of March 31, 2009, we have a $2.4 million valuation allowance against the value of our auction rate securities.
In February 2007, the FASB issued SFAS 159, “The Fair Value Option for Financial Assets and Financial Liabilities,” to permit all entities to choose to elect, at specified election dates, to measure eligible financial instruments at fair value. An entity shall report unrealized gains and losses on items for which the fair value option has been elected in earnings at each subsequent reporting date, and recognize upfront costs and fees related to those items in earnings as incurred and not deferred. SFAS 159 became effective for us as of July 1, 2008. As we did not elect the fair value option for our financial instruments (other than those already measured at fair value in accordance with SFAS No. 157), the adoption of this standard did not have an impact on our consolidated financial statements.
In March 2008, the FASB issued SFAS 161, “Disclosures about Derivative Instruments and Hedging Activities—an amendment of FASB Statement No. 133.” SFAS 161 requires qualitative disclosures about a company’s objectives and strategies for using derivative instruments, quantitative disclosures of the fair values and gains and losses of these derivative instruments in a tabular format, as well as more information about liquidity by requiring disclosure of a derivative contract’s credit-risk-related contingent features. SFAS 161 also requires cross-referencing within footnotes to enable financial statement users to locate important information about derivative instruments. We adopted this disclosure-only standard beginning in our fiscal 2009 third quarter.
Recently Issued Accounting Pronouncements Not Yet Adopted
In December 2007, the FASB issued SFAS 141(R), “Business Combinations.” SFAS 141(R) replaces SFAS 141. SFAS 141(R) establishes principles and requirements for how an acquirer recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, any non-controlling interest in the acquiree and the goodwill acquired. The Statement also establishes disclosure requirements which will enable users to evaluate the nature and financial effects of the business combination. SFAS 141(R) is effective for us for acquisitions consummated on or after July 1, 2009.
In December 2007, the FASB issued SFAS 160, “Noncontrolling Interests in Consolidated Financial Statements—an amendment of Accounting Research Bulletin No. 51.” SFAS 160 establishes accounting and reporting standards for ownership interests in subsidiaries held by parties other than the parent, the amount of consolidated net income attributable to the parent and to the noncontrolling interest, changes in a parent’s ownership interest and the valuation of retained noncontrolling equity investments when a subsidiary is deconsolidated. SFAS 160 also establishes reporting requirements that provide sufficient disclosures that clearly identify and distinguish between the interests of the parent and the interests of the noncontrolling owners. SFAS 160 is effective for fiscal years beginning after December 15, 2008. We are currently evaluating the impact, if any, the provisions of SFAS 160 will have on our consolidated financial statements.
- 11 - -
In April 2008, the FASB issued FSP FAS No. 142-3, “Determination of the Useful Life of Intangible Assets.” This FSP amends the factors that should be considered in developing renewal or extension assumptions used to determine the useful life of a recognized intangible asset under SFAS 142, “Goodwill and Other Intangible Assets.” This FSP also adds certain disclosures to those already prescribed in SFAS 142. FSP 142-3 becomes effective for the annual and interim periods within the year, beginning in our fiscal 2010. The guidance for determining useful lives must be applied prospectively to intangible assets acquired after the effective date. The disclosure requirements must be applied prospectively to all intangible assets recognized as of the effective date.
In November 2008, the FASB ratified the consensus reached on EITF Issue No. 08-6, “Accounting for Equity Method Investment Considerations.” EITF No. 08-6 addresses questions about the potential effect of SFAS No. 141(R) and SFAS No. 160 on equity-method accounting. The primary issues include how the initial carrying value of an equity method investment should be determined, how to account for any subsequent purchases and sales of additional ownership interests, and whether the investor must separately assess its underlying share of the investee’s indefinite-lived intangible assets for impairment. The effective date of EITF No. 08-6 coincides with that of SFAS No. 141(R) and SFAS No. 160 and is to be applied on a prospective basis beginning in our fiscal 2010. Early adoption is not permitted for entities that previously adopted an alternate accounting policy.
In April 2009, the FASB issued FSP No. FAS 107-1 and APB 28-1, “Interim Disclosures about Fair Value of Financial Instruments,” principally to require publicly traded companies to provide disclosures about fair value of financial instruments in interim financial information. The adoption of this disclosure-only guidance will not have an impact on our consolidated financial statements and is effective beginning with our fiscal 2009 interim period ending June 30, 2009.
In April 2009, the FASB issued FSP No. FAS 141(R)-1, “Accounting for Assets Acquired and Liabilities Assumed in a Business Combination That Arise from Contingencies,” to require that assets acquired and liabilities assumed in a business combination that arise from contingencies be recognized at fair value if fair value can be reasonably determined. If the fair value of such assets or liabilities cannot be reasonably determined, then they would generally be recognized in accordance with SFAS No. 5, “Accounting for Contingencies” and FASB Interpretation No. 14, “Reasonable Estimation of the Amount of a Loss – an interpretation of FASB Statement No. 5.” This FSP also amends the subsequent accounting for assets and liabilities arising from contingencies in a business combination and certain other disclosure requirements. This FSP is effective for the Company for assets or liabilities arising from contingencies in business combinations that are consummated on or after July 1, 2009.
In April 2009, the FASB issued FSP No. FAS 157-4, “Determining Fair Value When the Volume and Level of Activity for the Asset or Liability Have Significantly Decreased and Identifying Transactions That Are Not Orderly.” This FSP provides additional guidance for estimating fair value in accordance with SFAS No. 157 when there has been a significant decrease in market activity for a financial asset or liability in relation to normal activity and circumstances that may indicate that a transaction is not orderly. An entity is required to base its conclusion about whether a transaction was distressed on the weight of the evidence presented. This FSP also re-affirms that the objective of fair value, when the market for an asset is not active, is the price that would be received to sell the asset in an orderly market (as opposed to a distressed or forced transaction). Additional enhanced disclosures are also required in accordance with this FSP. FSP No. FAS 157-4 must be applied prospectively and is effective for interim and annual periods ending after June 15, 2009. We are currently evaluating the impact, if any, the provisions of FSP No. FAS 157-4 will have on our consolidated financial statements.
- 12 - -
In April 2009, the FASB issued FSP No. FAS 115-2 and FAS 124-2, Recognition and Presentation of Other-Than-Temporary Impairments (“FSP No. FAS 115-2”). FSP No. FAS 115-2 provides additional guidance on the timing of impairment recognition and greater clarity about the credit and noncredit components of impaired debt securities that are not expected to be sold. FSP No. FAS 115-2 also requires additional disclosures about impairments in interim and annual reporting periods. FSP No. FAS 115-2 is effective for the Company for the quarter ending June 30, 2009. We are currently evaluating the impact the provisions of FSP No. FAS 115-2 and FAS 124-2 will have on our consolidated financial statements.
2. | Discontinued Operations |
As a result of continued operating losses, in June 2007 our then board of directors approved a formal plan to divest our radar business (“Radar”) and to seek a strategic buyer. This business had previously been included in the Test Solutions segment. As a result of this decision, the operating results of Radar, net of taxes, had been classified in the consolidated statements of operations as discontinued operations for all periods presented. We recorded a loss on disposal of $3.7 million ($2.4 million, net of tax) in the predecessor period July 1, 2007 to August 14, 2007, to reflect the net assets of Radar at their net realizable value based on the May 15, 2008 sale of the business for $750,000. The sale agreement provided for additional contingent consideration, which was not included in the calculation of the loss on disposal as realization was not probable.
Net sales and income (loss) from discontinued operations (including impairment charges), which were solely related to Radar, were as follows:
Three Months | August 15, 2007 | July 1, 2007 | ||||||||||
Ended | to | to | ||||||||||
March 31, | March 31, | August 14, | ||||||||||
2008 | 2008 | 2007 | ||||||||||
Successor | Successor | Predecessor | ||||||||||
(In thousands) | ||||||||||||
Net sales | $ | 178 | $ | 756 | $ | 120 | ||||||
Income (loss) from discontinued operations before income taxes | $ | (1,190 | ) | $ | (3,021 | ) | $ | (3,861 | ) | |||
Income tax (benefit) | (222 | ) | (564 | ) | (1,353 | ) | ||||||
Income (loss) from discontinued operations | $ | (968 | ) | $ | (2,457 | ) | $ | (2,508 | ) |
3. | Company Sale Transaction |
The Merger on August 15, 2007 was funded by (i) a $378.4 million equity investment by Veritas, Golden Gate, GS Direct and certain members of our management, (ii) the majority of the proceeds from term loans aggregating $525 million and (iii) two exchangeable unsecured credit facilities totaling $345 million. An advisory agreement with the non-management equity investors or their designated affiliates requires us to pay advisory services fees of $2.3 million for fiscal 2009. Refer to Note 3 to our June 30, 2008 annual financial statements for complete details of our Merger and the Terminated Merger.
In connection with the Merger and Terminated Merger, for the three months ended March 31, 2008 and the periods from August 15, 2007 to March 31, 2008 and July 1, 2007 to August 14, 2007, we incurred Company sale transaction and related expenses that we expensed as incurred of $850,000, $32.5 million and $3.7 million, respectively, consisting primarily of merger-related severance and other change of control related payments, a merger termination fee and the related lawsuit settlement charge and legal and other professional fees (“Company Sale Transaction expenses”).
- 13 - -
The Merger constituted a change in control of the Company. The Company recorded its assets and liabilities at fair value as of the date of the Merger, whereby the purchase price was allocated to the assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. Independent third-party appraisers were engaged to assist management and perform valuations of certain of the tangible and intangible assets acquired.
We allocated the purchase price, including the acquisition costs of approximately $22.9 million, based on the estimated fair value of the assets acquired and liabilities assumed as follows:
(In thousands) | ||||
Current assets (excluding cash of $45.5 million) | $ | 335,252 | ||
Property, plant and equipment | 111,804 | |||
Other assets | 16,537 | |||
Developed technology | 195,500 | |||
Customer related intangible assets | 211,582 | |||
Other acquired intangible assets | 6,290 | |||
Intangible assets with indefinite lives (tradenames) | 122,870 | |||
Goodwill | 452,756 | |||
In-process research and development | 24,340 | |||
Total assets acquired | 1,476,931 | |||
Current liabilities | (137,751 | ) | ||
Long-term liabilities | (220,887 | ) | ||
Total liabilities assumed | (358,638 | ) | ||
Net assets acquired | $ | 1,118,293 |
At the acquisition date, the acquired in-process research and development (“IPR&D”) was not considered to have reached technological feasibility and had no alternative future uses. Therefore, the fair value of the IPR&D of $24.3 million was expensed at the time of the acquisition in operating costs. The allocation to IPR&D represents the estimated fair value of such incomplete research and development, at the acquisition date, based on future cash flows. As of the acquisition date, cash flows from these projects were expected to commence in fiscal year 2009. In determining the fair values of IPR&D, risk adjusted discount rates that ranged from 17% to 25% were applied to the projects’ cash flows, which have taken into account the respective projects’ completion percentage.
The unaudited pro forma results of operations presented below for the period from July 1, 2007 to August 14, 2007 are presented as though the Merger had occurred on July 1, 2006, after giving effect to purchase accounting adjustments relating to depreciation and amortization of the revalued assets, interest expense associated with the new credit facilities and other acquisition-related adjustments in connection with the Merger. The pro forma results of operations are not necessarily indicative of the combined results that would have occurred had the Merger been consummated at July 1, 2006, nor are they necessarily indicative of future operating results.
Period from | ||||
July 1, 2007 to | ||||
August 14, 2007 | ||||
Predecessor | ||||
(In thousands) | ||||
Net sales | $ | 38,178 | ||
Net income (loss) | $ | (27,554 | ) |
- 14 - -
In connection with the consummation of the Merger, we entered into amended employment agreements with all participants, excluding one retired participant, in our unfunded Supplemental Executive Retirement Plan (“the “SERP”) that provided for specified payments, plus, for certain participants, 6% interest per annum from August 15, 2007, in full satisfaction of the benefits payable under the SERP. In accordance with the terms of those agreements, we made a payment of $16.6 million in December 2008 and a final payment of $3.2 million in January 2009. The actuarially determined liability to the one remaining retired participant in the SERP, who will receive monthly payments through at least December 15, 2015, was $6.7 million at March 31, 2009, of which $628,000 and $6.0 million is included in Accrued Expenses and Defined Benefit Plan Obligations, respectively.
4. | Acquisition of Businesses and Intangible Assets |
Test Evolution Corporation
On October 1, 2007, we purchased 40% of the outstanding stock of Test Evolution Corporation (“TEC”) for $4.0 million ($2.0 million at closing and $2.0 million paid in October 2008). TEC, located in Massachusetts, develops and manufactures digital, analog and RF semiconductor automated test equipment. We have determined that we have control of this company and have consolidated TEC’s assets and liabilities and results of operations, all of which were insignificant, into our financial statements commencing October 1, 2007. The non-controlling interest of 60% in each of the equity and operations of TEC are not material to our consolidated financial statements and have been included in other long-term liabilities and other income (expense), respectively. TEC is included in our Test Solutions segment.
Gaisler Research AB
On June 30, 2008, we acquired the stock of Gaisler Research AB (“Gaisler”) for $12.3 million cash (net of $2.7 million cash acquired), plus up to another $15 million over the next three years provided specified EBITDA targets are achieved. Located in Sweden, Gaisler provides integrated circuit software products and services to European space system suppliers, plus other U.S., Japanese and Russian space agencies. Gaisler is included in our Microelectronic Solutions segment.
We allocated the purchase price, including acquisition costs of approximately $379,000, based on the estimated fair value of the assets acquired and liabilities assumed as follows:
(In thousands) | ||||
Current assets (excluding cash of $2.7 million) | $ | 987 | ||
Property, plant and equipment | 62 | |||
Developed technology | 7,550 | |||
Customer related intangibles | 1,030 | |||
Non-compete arrangements | 1,820 | |||
Tradenames | 1,190 | |||
Goodwill | 2,069 | |||
In-process research and development | 2,300 | |||
Total assets acquired | 17,008 | |||
Current liabilities | (1,076 | ) | ||
Deferred taxes | (3,245 | ) | ||
Total liabilities assumed | (4,321 | ) | ||
Net assets acquired | $ | 12,687 |
The customer related intangibles and developed technology are being amortized on a straight-line basis over a range of 1 to 8 years.
- 15 - -
On a pro forma basis, had the Gaisler acquisition taken place as of the beginning of fiscal 2008, our results of operations would not have been materially affected.
VI Technology, Inc.
On March 4, 2009, we acquired 100% of the stock of VI Technology, Inc. (VI Tech). We paid $5.0 million in cash for approximately 29% of the stock of VI Tech, and the remaining approximately 71% of VI Tech stock was acquired by a limited liability company (parent LLC), that is our ultimate parent, in exchange for Class A membership interests in parent LLC with a fair value of $12.7 million. Immediately following the consummation of these transactions, parent LLC contributed the 71% of VI Tech stock to the Company, giving us 100% ownership in VI Tech. VI Tech, located in Austin, Texas, designs and manufactures independent automated test systems. VI Tech is included in our Test Solutions segment.
We preliminarily allocated the purchase price, including acquisition costs of approximately $348,000, based on the estimated fair value of the assets acquired and liabilities assumed as follows:
(In thousands) | ||||
Current assets (excluding cash of $107,000) | $ | 2,015 | ||
Property, plant and equipment | 149 | |||
Other assets | 37 | |||
Developed technology | 3,752 | |||
Customer related intangibles | 3,252 | |||
Tradenames | 1,042 | |||
Non-compete arrangements | 834 | |||
Goodwill | 11,428 | |||
In-process research and development | 626 | |||
Total assets acquired | 23,135 | |||
Current liabilities | (1,908 | ) | ||
Deferred taxes | (3,286 | ) | ||
Total liabilities assumed | (5,194 | ) | ||
Net assets acquired | $ | 17,941 |
The customer related intangibles and developed technology are being amortized on a straight-line basis over a range of 1 to 7 years.
On a pro forma basis, had the VI Tech acquisition taken place as of the beginning of fiscal 2009, our results of operations would not have been materially affected.
Intangible Assets with Definite Lives
The components of amortizable intangible assets are as follows:
March 31, 2009 | June 30, 2008 | |||||||||||||||
(In thousands) | ||||||||||||||||
Gross | Gross | |||||||||||||||
Carrying | Accumulated | Carrying | Accumulated | |||||||||||||
Amount | Amortization | Amount | Amortization | |||||||||||||
Developed technology | $ | 195,085 | $ | 52,455 | $ | 198,420 | $ | 29,631 | ||||||||
Customer related intangibles | 209,587 | 62,528 | 213,232 | 42,433 | ||||||||||||
Non-compete arrangements | 9,247 | 2,142 | 6,290 | 1,012 | ||||||||||||
Tradenames | 1,907 | 107 | - | - | ||||||||||||
Total | $ | 415,826 | $ | 117,232 | $ | 417,942 | $ | 73,076 |
- 16 - -
The aggregate amortization expense for amortizable intangible assets was $15.0 million and $20.9 million for the three months ended March 31, 2009 and 2008, respectively, and $47.5 million, $52.3 million and $1.7 million for the nine months ended March 31, 2009 and the periods August 15, 2007 to March 31, 2008 and July 1, 2007 to August 14, 2007, respectively.
The estimated aggregate amortization expense for each of the twelve-month periods ending March 31, is as follows:
(In thousands) | ||||
2010 | $ | 59,359 | ||
2011 | 58,514 | |||
2012 | 58,313 | |||
2013 | 54,495 | |||
2014 | 35,241 |
Goodwill
The carrying amount of goodwill is as follows:
AMS | ATS | Total | ||||||||||
(In thousands) | ||||||||||||
Balance at June 30, 2007 (predecessor entity) | $ | 51,321 | $ | 130,641 | $ | 181,962 | ||||||
Goodwill adjustment recorded in purchase accounting from allocation of purchase price (1) | 243,456 | 27,373 | 270,829 | |||||||||
Balance at August 15, 2007 (successor entity) | 294,777 | 158,014 | 452,791 | |||||||||
Acquisition of Test Evolution Corporation | - | 1,868 | 1,868 | |||||||||
Acquisition of Gaisler | 8,261 | - | 8,261 | |||||||||
Impact of foreign currency translation | (268 | ) | (1,497 | ) | (1,765 | ) | ||||||
Balance at June 30, 2008 (successor entity) | 302,770 | 158,385 | 461,155 | |||||||||
Final adjustment to goodwill related to the Merger | 494 | (529 | ) | (35 | ) | |||||||
Adjustment to goodwill for acquisitions(2) | (5,985 | ) | 11,428 | 5,443 | ||||||||
Impact of foreign currency translation | (1,102 | ) | (11,209 | ) | (12,311 | ) | ||||||
Balance at March 31, 2009 (successor entity) | $ | 296,177 | $ | 158,075 | $ | 454,252 |
(1) The predecessor entity goodwill has been written off in purchase accounting for the Merger.
(2) Goodwill was adjusted primarily due to finalizing purchase accounting for the Gaisler acquisition in the amount of $(6.2) million and the VI Tech acquisition in the amount of $11.4 million.
5. | Restructuring Charges |
In fiscal 2008, we initiated actions to restructure our U.K. business units by further consolidating our manufacturing, research and development and selling, general and administrative activities. In addition, we initiated a restructuring in our Whippany, New Jersey, component manufacturing facility to address a slowdown in sales of its integrated products line. These actions resulted in the termination of approximately 151 employees, which resulted in restructuring costs, principally severance, for the periods from August 15, 2007 to March 31, 2008 and July 1, 2007 to August 14, 2007 of $1.8 million ($486,000 in cost of sales, $498,000 in selling, general and administrative costs and $820,000 in research and development costs) and $3.8 million ($1.6 million in selling, general and administrative costs and $2.2 million in research and development costs), respectively. Substantially all of the workforce reduction costs were paid prior to June 30, 2008. In May 2008, we incurred other restructuring charges including $2.6 million of accrued contractual commitments under operating leases for two facilities in the U.K. that we exited, which will be paid through December 2010. In addition, approximately $485,000 of fixed asset impairment charges were recorded in selling, general and administrative costs in the fourth quarter of fiscal 2008 for the write-off of leasehold improvements in the abandoned facilities.
- 17 - -
For the nine months ended March 31, 2009, in connection with continued restructuring activities of certain manufacturing operations, we incurred $2.8 million of severance costs for an additional 61 employees terminated primarily in our U.K. business unit ($2.0 million in cost of sales, $463,000 in selling, general and administrative costs and $303,000 in research and development costs).
The following table sets forth the charges and payments related to the restructuring liability for the periods indicated:
Balance | Balance | |||||||||||||||||||
June 30, | March 31, | |||||||||||||||||||
2008 | Nine Months Ended March 31, 2009 | 2009 | ||||||||||||||||||
Effect of | ||||||||||||||||||||
Restructuring | foreign | Restructuring | ||||||||||||||||||
Liability | Net Additions | Cash Payments | currency | Liability | ||||||||||||||||
(In thousands) | ||||||||||||||||||||
Work force reduction | $ | 12 | $ | 2,792 | $ | (2,334 | ) | $ | (4 | ) | $ | 466 | ||||||||
Other | 3,242 | - | (902 | ) | (863 | ) | 1,477 | |||||||||||||
Total | $ | 3,254 | $ | 2,792 | $ | (3,236 | ) | $ | (867 | ) | $ | 1,943 |
6. | Inventories |
Inventories consist of the following:
March 31, | June 30, | |||||||
2009 | 2008 | |||||||
(In thousands) | ||||||||
Raw materials | $ | 64,421 | $ | 64,533 | ||||
Work in process | 52,868 | 41,056 | ||||||
Finished goods | 20,565 | 29,302 | ||||||
$ | 137,854 | $ | 134,891 |
7. | Product Warranty |
We warrant our products against defects in design, materials and workmanship, generally for one year from their date of shipment. A provision for estimated future costs relating to these warranties is recorded when the related revenue is recognized and is included in cost of sales. Quarterly we analyze our warranty liability for reasonableness based on a 15-month history of warranty costs incurred, the nature of the products shipped subject to warranty and anticipated warranty trends.
- 18 - -
Activity related to our product warranty liability, which is reflected in accrued expenses and other current liabilities in the accompanying consolidated balance sheets, was as follows:
Nine Months | August 15, 2007 | July 1, 2007 | ||||||||||
Ended | to | to | ||||||||||
March 31, | March 31, | August 14, | ||||||||||
2009 | 2008 | 2007 | ||||||||||
Successor | Successor | Predecessor | ||||||||||
(In thousands) | ||||||||||||
Balance at beginning of period | $ | 2,944 | $ | 3,002 | $ | 2,929 | ||||||
Provision for warranty obligations | 2,028 | 2,136 | 469 | |||||||||
Cost of warranty obligations | (2,147 | ) | (2,115 | ) | (394 | ) | ||||||
Foreign currency impact | (285 | ) | 7 | (2 | ) | |||||||
Balance at end of period | $ | 2,540 | $ | 3,030 | $ | 3,002 |
8. | Derivative Financial Instruments |
We adopted SFAS No. 161 as of January 1, 2009. The adoption did not have an impact on our consolidated financial statements as it is a disclosure-only standard. We address certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments. We enter into interest rate swap derivatives to manage the effects of interest rate movements on portions of our debt. We also enter into foreign currency forward contracts, not designated as hedging instruments, to protect us from fluctuations in exchange rates.
The fair values of our derivative financial instruments included in the condensed consolidated balance sheet as of March 31, 2009 are presented as follows:
Asset Derivatives | Liability Derivatives | |||||||||
Balance Sheet | Balance Sheet | |||||||||
(In thousands) | Location | Fair Value(1) | Location | Fair Value(1) | ||||||
Derivatives designated as hedging instruments: | ||||||||||
Interest rate swap contracts | ||||||||||
Not applicable | $ | - | Other long-term liabilities | $ | 17,436 | |||||
Derivatives not designated as hedging instruments: | ||||||||||
Foreign currency forward contracts | ||||||||||
Not applicable | - | Accrued expenses and other current liabilities | 33 | |||||||
Total Derivatives | $ | - | $ | 17,469 |
(1) See Note 9 for further information about how the fair values of derivative assets and liabilities are determined.
- 19 - -
The amounts of the gains and losses related to our derivative financial instruments designated as hedging instruments are presented as follows:
Location of Gain or (Loss) | Amount of Gain or (Loss) | ||||||||||||||||
Amount of Gain or (Loss) | Reclassified from | Reclassified from | |||||||||||||||
Recognized in OCI on Derivative | Accumulated OCI into | Accumulated OCI into | |||||||||||||||
(In thousands) | (Effective Portion) (1) | Income (Effective Portion) | Income (Effective Portion) | ||||||||||||||
Three Months | Nine Months | Three Months | Nine Months | ||||||||||||||
Derivatives in Cash Flow | Ended | Ended | Ended | Ended | |||||||||||||
Hedging Relationships | March 31, 2009 | March 31, 2009 | March 31, 2009 | March 31, 2009 | |||||||||||||
Interest rate swap contracts | $ | 479 | $ | (12,396 | ) | Interest expense | $ | (2,079 | ) | $ | (4,161 | ) |
(1) See Note 12 for additional information on changes to other accumulated comprehensive income (loss).
The amounts of the gains and losses related to our derivative financial instruments not designated as hedging instruments are presented as follows:
Location of Gain or (Loss) | Amount of Gain or (Loss) | ||||||
Recognized in Earnings on | Recognized in Earnings on | ||||||
(In thousands) | Derivative | Derivative | |||||
Three Months | Nine Months | ||||||
Ended | Ended | ||||||
March 31, 2009 | March 31, 2009 | ||||||
Derivatives Not Designated as Hedging | |||||||
Instruments: | |||||||
Foreign currency forward contracts | Other income (expense) | $ | 759 | $ | (46) |
Interest Rate Swap Cash-Flow Hedges
We enter into interest rate swap contracts to manage the effects of interest rate movements on portions of our debt. Such contracts effectively fix the borrowing rates on floating rate debt to limit the exposure against the risk of rising rates. We do not enter into interest rate swap contracts for speculative purposes and we have entered into transactions with counterparties that are rated investment grade. Our interest rate swap contracts, all of which were entered into in fiscal 2008 for an aggregate notional amount of $475 million, have varying maturities through February 2011.
Foreign Currency Contract Derivatives |
Foreign currency contracts are used to protect us from fluctuations in exchange rates. We enter into foreign currency contracts, which are not designated as hedges. Thus the change in fair value is included in income as it occurs, within other income (expense). As of March 31, 2009, we had $10.7 million of notional value foreign currency forward contracts maturing through June 2009. Notional amounts do not quantify risk or represent assets or liabilities of the Company, but are used in the calculation of cash settlements under the contracts.
9. | Fair Value Measurements |
We adopted the provisions of SFAS 157 for financial assets and liabilities as of July 1, 2008 and, as of March 31, 2009, have recorded a $2.4 million valuation allowance against the cost of our auction rate securities. SFAS 157 defines fair value as the price that would be received to sell an asset or paid to transfer a liability, in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants at the measurement date. SFAS 157 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
- 20 - -
SFAS 157 describes three levels of inputs that may be used to measure fair value:
Level 1: | Inputs based on quoted market prices for identical assets or liabilities in active markets at the measurement date. |
Level 2: | Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. |
Level 3: | Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instruments valuation. |
The following table presents for each hierarchy level, financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2009:
Quoted Prices in | ||||||||||||||||
Active Markets | Significant Other | Significant | ||||||||||||||
for Identical | Observable | Unobservable | ||||||||||||||
Assets | Inputs | Inputs | ||||||||||||||
(Level 1) | (Level 2) | (Level 3) | Total | |||||||||||||
(In thousands) | ||||||||||||||||
Assets: | ||||||||||||||||
Non-current marketable securities | $ | - | $ | - | $ | 17,523 | $ | 17,523 | ||||||||
Liabilities: | ||||||||||||||||
Foreign currency forward | ||||||||||||||||
contracts | $ | - | $ | 33 | $ | - | $ | 33 | ||||||||
Interest rate swap contracts | - | 17,436 | - | 17,436 | ||||||||||||
Total Liabilities | $ | - | $ | 17,469 | $ | - | $ | 17,469 |
The following table presents the changes in the carrying value of the Company’s assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3), as defined in SFAS No. 157, for the nine months ended March 31, 2009:
Fair Value Measurements | ||||
Using Significant | ||||
Unobservable Inputs | ||||
(Level 3) | ||||
Auction | ||||
Rate | ||||
Securities | ||||
(In thousands) | ||||
Balance at June 30, 2008 | $ | - | ||
Transfers to Level 3 | 19,945 | |||
Total unrealized losses in accumulated other comprehensive income (loss) | (2,422 | ) | ||
Balance at March 31, 2009 | $ | 17,523 |
Non-Current Marketable Securities – Non-current marketable securities consist of auction rate securities that currently have no active market from which we could obtain pricing. Since we adopted SFAS 157 on July 1, 2008, auction rate securities have been classified as Level 3 as their valuation requires substantial judgment and estimation of factors that are not currently observable in the market due to the lack of trading in the securities. Since February 2008, when auctions for these securities began to fail, we have redeemed $26.5 million of auction rate securities at par. To date, we have collected all interest payments on all our auction rate securities when due. Furthermore, we have the intent and are able to hold these securities until the credit markets recover, or until maturity, if necessary. However, based on a discounted cash flow analysis, which considered, among other items, the collateral underlying the securities, the credit worthiness of the issuer, the timing of future cash flows and liquidity risks, we have recorded a $2.4 million valuation allowance against the auction rate securities.
- 21 - -
Foreign Currency Forward Contracts – The fair value of our foreign currency forward contracts were valued using a pricing model with all significant inputs based on observable market data such as measurement date spot and forward rates.
Interest Rate Swap Contracts – The fair value of our outstanding interest rate swap contracts were based on valuations received from the counterparties and corroborated by measurement date equivalent swap rates.
10. | Long Term Debt and Credit Agreements |
On August 7, 2008, our 11.75% exchangeable senior unsecured loan in the amount of $225 million with an ultimate maturity on February 15, 2015 was refinanced with unsecured senior notes with the same interest rate and maturity date. We may prepay the senior notes commencing August 15, 2011 at 105.875% of the principal amount prepaid, which decreases to 102.938% on August 15, 2012 and to 100% on or after August 15, 2013. In addition, we may redeem up to 35% of the original aggregate principal balance of the senior notes, at any time prior to August 15, 2010, with the net proceeds of certain equity offerings at 111.75% of the principal amount redeemed. On January 21, 2009, the SEC declared effective our exchange offer registration statement which resulted in the exchange of the unregistered unsecured senior notes for publicly registered 11.75% unsecured senior notes due February 15, 2015 with substantially identical terms as the exchanged notes.
As of March 31, 2009, we are in compliance with all of the covenants contained in our loan agreements.
In connection with our credit facilities, we capitalized deferred financing costs of $340,000, $27.4 million and $477,000 for the nine months ended March 31, 2009 and the periods August 15, 2007 to March 31, 2008 and July 1, 2007 to August 14, 2007, respectively, primarily consisting of facility, legal and advisory fees. We are amortizing these costs over the terms of the related facilities. For the three months ended March 31, 2009 and 2008 we amortized $1.2 million and $1.6 million, respectively, to interest expense. For the nine months ended March 31, 2009 and the periods August 15, 2007 to March 31, 2008 and July 1, 2007 to August 14, 2007, we amortized $3.6 million, $2.8 million and $217,000, respectively, to interest expense.
Interest paid was $44.1 million for the nine months ended March 31, 2009, $35.7 million for the period August 15, 2007 to March 31, 2008, and $57,000 for the period July 1, 2007 to August 14, 2007.
- 22 - -
The fair value of our debt instruments are summarized as follows:
March 31, 2009 | ||||||||
Carrying | Estimated | |||||||
Amount | Fair Value | |||||||
(In thousands) | ||||||||
Senior secured B-1 term loan | $ | 393,857 | $ | 248,130 | ||||
Senior secured B-2 term loan | 123,080 | 60,309 | ||||||
Senior unsecured loan | 225,000 | 140,625 | ||||||
Senior subordinated unsecured term loan | 143,253 | 75,208 | ||||||
Other | 1,406 | 1,406 | ||||||
Total debt | $ | 886,596 | $ | 525,678 |
The carrying value of debt of $878.8 million as of June 30, 2008 had a fair value of $804.2 million.
The estimated fair values of each of our debt instruments are based on quoted market prices for the same or similar issues. Fair value estimates related to our debt instruments are made at a specific point in time based on relevant market information. These estimates are subjective in nature and involve uncertainties and matters of significant judgments and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.
11. | Stockholder’s Equity |
Share Based Compensation
Stock Options
All of our Predecessor Entity stock option plans were terminated on August 15, 2007. The Merger agreement provided that all stock options were cancelled and converted into the right to receive a cash payment equal to the number of shares of our common stock underlying the options multiplied by that amount, if any, by which $14.50 exceeded the exercise price, without interest and less any withholding taxes. On August 15, 2007 we paid $43.9 million to option holders to cancel all options outstanding in connection with the Merger.
Member Interests
On August 15, 2007 certain members of our management were granted Class B member interests in a limited liability company (parent LLC) that is the ultimate parent of the Company, and which owns all of the common stock of the Parent. The parent LLC is a holding company with no operations or employees of its own. The parent LLC has two classes of membership interests, Class A and Class B. Our non-management equity investors, or their affiliates, the selling shareholders of VI Tech and Company employees that made equity investments to partially fund the Merger are Class A members and Class B members consist of Company employees. Pursuant to the terms of the limited liability company operating agreement governing the parent LLC, the holders of Class B member interests are entitled to receive a percentage of all distributions, if any, made by the parent LLC after (x) the holders of the Class A members in the parent LLC have received a return of their invested capital, plus a 12% per annum internal rate of return (compounded annually) on their invested capital and (y) certain members of our management that received Class A interests for their capital contributions have received a special distribution in the aggregate amount of $3.2 million, together with a 12% per annum internal rate of return (compounded annually). The Class B member interests are non-transferable and vest ratably over five years, with any unvested interests reverting to the holders of Class A interests in the event they are forfeited or repurchased.
- 23 - -
Compensation expense attributable to share based compensation was $489,000 ($308,000 after tax) and $488,000 ($307,000 after tax) for the three months ended March 31, 2009 and 2008, respectively, $1.5 million ($924,000 after tax) for the nine months ended March 31, 2009, $2.6 million ($1.7 million after tax) for the period August 15, 2007 to March 31, 2008 and $214,000 ($135,000 after tax) for the period July 1, 2007 to August 14, 2007.
A summary of the changes to outstanding stock options from July 1, 2007 to August 15, 2007 is presented below:
Weighted | ||||||||
Average | ||||||||
Exercise | ||||||||
Shares | Price | |||||||
(In thousands) | ||||||||
Outstanding at June 30, 2007 | 13,003 | $ | 12.37 | |||||
Granted | - | - | ||||||
Forfeited | (27 | ) | 19.30 | |||||
Expired | - | - | ||||||
Exercised | (51 | ) | 11.39 | |||||
Cancelled | (3,825 | ) | 18.74 | |||||
Paid out on Merger | (9,100 | ) | 9.68 | |||||
Outstanding at August 15, 2007 | - |
Cash received from stock option exercises was $583,000 for the period July 1, 2007 to August 14, 2007. The tax benefit received from stock option exercises was $16.1 million for the period August 15, 2007 to March 31, 2008 and $41,000 for the period July 1, 2007 to August 14, 2007.
12. Comprehensive Income
The components of comprehensive income (loss) are as follows:
Three Months | Three Months | Nine Months | August 15, 2007 | July 1, 2007 | ||||||||||||||||
Ended | Ended | Ended | to | to | ||||||||||||||||
March 31, | March 31, | March 31, | March 31, | August 14, | ||||||||||||||||
2009 | 2008 | 2009 | 2008 | 2007 | ||||||||||||||||
Successor | Successor | Successor | Successor | Predecessor | ||||||||||||||||
(In thousands) | ||||||||||||||||||||
Net income (loss) | $ | (13,734 | ) | $ | (16,405 | ) | $ | (24,738 | ) | $ | (96,498 | ) | $ | (16,916 | ) | |||||
Unrealized gain (loss) on interest rate swap contracts, net of tax provision (benefit) of $282,000, ($1.5 million), ($7.3 million), ($2.9 million) and $0 | 479 | (2,491 | ) | (12,396 | ) | (4,952 | ) | - | ||||||||||||
Valuation allowance against non-current marketable securities | (219 | ) | - | (2,422 | ) | - | - | |||||||||||||
Foreign currency translation adjustment | (4,467 | ) | (1,030 | ) | (60,447 | ) | (1,641 | ) | (497 | ) | ||||||||||
Total comprehensive income (loss) | $ | (17,941 | ) | $ | (19,926 | ) | $ | (100,003 | ) | $ | (103,091 | ) | $ | (17,413 | ) |
- 24 - -
Accumulated other comprehensive income (loss) is as follows:
Unrealized | ||||||||||||||||||||
Gain (Loss) | Valuation | Minimum | ||||||||||||||||||
on Interest | Allowance Against | Pension | Foreign | |||||||||||||||||
Rate Swap | Non-Current | Liability | Currency | |||||||||||||||||
Agreements | Marketable | Adjustment | Translation | Total | ||||||||||||||||
(net of tax) | Securities | (net of tax) | Adjustment | (net of tax) | ||||||||||||||||
(In thousands) | ||||||||||||||||||||
Balance, June 30, 2008 | $ | 1,411 | $ | - | $ | (6 | ) | $ | (998 | ) | $ | 407 | ||||||||
Nine months' activity | (12,396 | ) | (2,422 | ) | - | (60,447 | ) | (75,265 | ) | |||||||||||
Balance, March 31, 2009 | $ | (10,985 | ) | $ | (2,422 | ) | $ | (6 | ) | $ | (61,445 | ) | $ | (74,858 | ) |
The foreign currency translation adjustments are not adjusted for income taxes as they relate to indefinite investments in non-U.S. subsidiaries. The valuation allowance for non-current marketable securities is not adjusted for income taxes as it would create a capital loss carryforward upon realization for which we would record a valuation allowance against the related deferred tax asset.
13. | Legal Matters |
In March 2005, we sold the net assets of our shock and vibration control device manufacturing business (“VMC”). Under the terms of the sale agreements, we retained certain liabilities relating to adverse environmental conditions that existed at the premises occupied by VMC as of the date of sale. We recorded a liability for the estimated remediation costs related to adverse environmental conditions that existed at the VMC premises when it was sold. The accrued environmental liability at March 31, 2009 is $1.0 million, of which $322,000 is expected to be paid within one year.
During the quarter ended March 31, 2007, we became aware that certain RadHard bidirectional multipurpose transceivers sold by us since 1999 may have been subject to the licensing jurisdiction of the U.S. Department of State in accordance with the International Traffic in Arms Regulations (“ITAR”). Accordingly, we filed a Voluntary Disclosure with the Directorate of Defense Trade Controls, Department of State, describing the details of the possible inadvertent misclassification. Simultaneously, we filed a Commodity Jurisdiction request providing detailed information and data supporting our contention that the product is not subject to ITAR and requesting a determination that such product is not ITAR controlled. By letter dated November 15, 2007, we were informed that the U.S. Department of State had determined in response to our Commodity Jurisdiction request, that the product is subject to the licensing jurisdiction of the U.S. Department of State in accordance with ITAR. We requested reconsideration of this determination. On February 7, 2008, we filed an addendum to the above referenced Voluntary Disclosure advising the Directorate of Defense Trade Controls that other products sold by us similar in nature to the transceiver described above may also be subject to the ITAR. The Directorate of Defense Trade Controls agreed to extend our time to file such addendum to the Voluntary Disclosure until a decision was rendered with respect to our request for reconsideration of the determination in connection with the above-referenced Commodity Jurisdiction request. On August 5, 2008, we received a letter from the Office of Defense Trade Controls Compliance (“DTCC”) requesting that we provide documentation and/or information relating to our compliance initiatives after November 15, 2007 as well as the results of any product reviews conducted by us, and indicating that a civil penalty against us could be warranted in connection with this matter following the review of such materials. We have provided all of the materials and documentation requested by the DTCC. Our request for reconsideration was denied by the Directorate of Defense Trade Controls on August 19, 2008 which determined that the product is subject to the licensing jurisdiction of the Department of State in accordance with ITAR. Accordingly, on September 18, 2008, we filed an addendum to our Voluntary Disclosure identifying other products that may have been subject to the licensing jurisdiction of the U.S. Department of State in accordance with the ITAR but were inadvertently misclassified. At this time it is not possible to determine whether any fines or other penalties will be asserted against us, or the materiality of any outcome.
- 25 - -
During May 2008, we became further aware that a certain product sold by our KDI subsidiary may have inadvertently been misclassified as not ITAR controlled. On August 5, 2008, we filed a Voluntary Disclosure with the Directorate of Defense Trade Controls, Department of State, describing the inadvertent misclassification of this product. In January 2009 we identified another product that should have been included in the August 5, 2008 disclosure. We filed an initial disclosure with the Department of State identifying this product, and the Department of State instructed us to file an amendment to the August 5, 2008 disclosure. That amendment was filed in April 2009. At this time it is not possible to determine whether any fines or other penalties will be asserted against us with respect to the foregoing matters, or the materiality of any outcome.
During November 2008, we became aware that our Hauppauge facility had shipped two ITAR controlled products to a foreign customer, but inadvertently had noted on the requisite paperwork that only one ITAR controlled product was included in the shipment. We filed a voluntary disclosure in January 2009, and that disclosure has been closed by the State Department and no fine or penalty was assessed.
During January 2009, we became aware that a certain product sold by our Powell subsidiary, for which an ITAR marketing license had been properly issued by the U.S. Department of State, mistakenly was taken out of the country by an employee without first obtaining the required U.S. Customs signature upon departure. We have filed an initial disclosure relating to this issue and will file a detailed disclosure by June 6, 2009. At this time it is not possible to determine whether any fines or other penalties will be asserted against us, or the materiality of any outcome.
In the third quarter of fiscal 2009, we became aware that a product sold and licensed to Raytheon U.K. was actually forwarded to an end user in Saudi Arabia. Aeroflex did not identify that end user on the initial license application, so the product in question was forwarded to Saudi Arabia when it was only authorized to travel as far as the U.K. We filed an initial disclosure concerning this matter in April 2009. At this time it is not possible to determine whether any fines or penalties will be asserted against us, or the materiality of any outcome.
In March 2009 we became aware that Aeroflex’s subsidiary, Micrometrics, had inadvertently misclassified a component and shipped it to a foreign customer in Italy under the jurisdiction of the Export Administration Regulations (“EAR”) when it should have been shipped under the jurisdiction of the ITAR. We filed an initial voluntary disclosure concerning this matter in April 2009. At this time it is not possible to determine whether any fines or penalties will be asserted against us, or the materiality of any outcome.
An amended class action complaint was filed against us and the Predecessor Entity’s board of directors on June 20, 2007 in the Supreme Court of the State of New York, Nassau County. The complaint alleges that the board breached its fiduciary duties to our stockholders (i) by issuing a preliminary proxy statement on June 5, 2007 that was issued in connection with seeking stockholder approval of the Merger and (ii) in approving certain amendments, that were allegedly beyond the scope of our corporate powers, to our SERP and the employment agreements of defendants Harvey R. Blau, our then Chairman and Chief Executive Officer, and Leonard Borow, our then President and Chief Operating Officer and currently, the Successor Entity’s President and Chief Executive Officer. We are currently in settlement discussions with the plaintiffs and have accrued an insignificant liability for the settlement.
- 26 - -
We are also involved in various other claims and legal actions that arise in the ordinary course of business. We do not believe that the ultimate resolution of any of these actions will have a material adverse effect on our financial position, results of operations, liquidity or capital resources.
14. | Business Segments |
Our business segments and major products included in each segment, are as follows:
Microelectronic Solutions (“AMS”)
· | Microelectronic Components, Sub-assemblies and Modules |
· | Integrated Circuits |
· | Motion Control Systems |
Test Solutions (“ATS”)
· | Instrument Products and Test Systems |
We are a manufacturer of advanced technology systems and components for commercial industry, government and defense contractors. Approximately 35% of our sales for the nine months ended March 31, 2009, 29% of our sales for the period August 15, 2007 to March 31, 2008 and 21% for the period July 1, 2007 to August 14, 2007 were to agencies of the United States government or to prime defense contractors or subcontractors of the United States government. No one customer constituted more than 10% of sales during any of the periods presented. Inter-segment sales were not material and have been eliminated from the tables below.
The majority of our operations are located in the United States; however, we also have operations in Europe and Asia, with our most significant international operations in the U.K. Net sales from facilities located in the U.K. were approximately $32.2 million and $37.9 million for the three months ended March 31, 2009 and 2008, respectively, and $100.0 million, $114.7 million and $11.7 million for the nine months ended March 31, 2009 and the periods August 15, 2007 to March 31, 2008 and July 1, 2007 to August 14, 2007, respectively. Total assets of the U.K. operations were $167.3 million and $237.5 million as of March 31, 2009 and June 30, 2008, respectively.
Net sales, based on the customers’ locations, attributed to the United States and other regions are as follows:
Three Months | Three Months | Nine Months | August 15, 2007 | July 1, 2007 | ||||||||||||||||
Ended | Ended | Ended | to | to | ||||||||||||||||
March 31, | March 31, | March 31, | March 31, | August 14, | ||||||||||||||||
2009 | 2008 | 2009 | 2008 | 2007 | ||||||||||||||||
(Successor) | (Successor) | (Successor) | (Successor) | (Predecessor) | ||||||||||||||||
(In thousands) | ||||||||||||||||||||
United States of America | $ | 79,397 | $ | 82,942 | $ | 251,454 | $ | 229,914 | $ | 21,183 | ||||||||||
Europe and Middle East | 43,583 | 36,318 | 103,481 | 97,604 | 10,357 | |||||||||||||||
Asia and Australia | 14,201 | 34,273 | 75,263 | 85,358 | 6,242 | |||||||||||||||
Other regions | 2,258 | 3,771 | 6,901 | 7,200 | 439 | |||||||||||||||
$ | 139,439 | $ | 157,304 | $ | 437,099 | $ | 420,076 | $ | 38,221 |
- 27 - -
Selected financial data by segment is as follows:
August 15, | ||||||||||||||||||||
Three Months | Three Months | Nine Months | 2007 | |||||||||||||||||
Ended | Ended | Ended | through | July 1, 2007 | ||||||||||||||||
March 31, | March 31, | March 31, | March 31, | to August 14, | ||||||||||||||||
2009 | 2008 | 2009 | 2008 | 2007 | ||||||||||||||||
(Successor) | (Successor) | (Successor) | (Successor) | (Predecessor) | ||||||||||||||||
(In thousands) | ||||||||||||||||||||
Net sales: | ||||||||||||||||||||
Microelectronic solutions ("AMS") | $ | 70,232 | $ | 77,380 | $ | 208,564 | $ | 197,279 | $ | 19,017 | ||||||||||
Test solutions ("ATS") | 69,207 | 79,924 | 228,535 | 222,797 | 19,204 | |||||||||||||||
Net sales | $ | 139,439 | $ | 157,304 | $ | 437,099 | $ | 420,076 | $ | 38,221 | ||||||||||
Segment adjusted operating income: | ||||||||||||||||||||
- AMS | $ | 14,783 | $ | 19,143 | $ | 44,767 | $ | 51,363 | $ | 24 | ||||||||||
- ATS | 8,700 | 11,010 | 34,304 | 34,367 | (7,582 | ) | ||||||||||||||
- General corporate expense | (2,854 | ) | (2,088 | ) | (9,421 | ) | (5,497 | ) | (2,347 | ) | ||||||||||
Adjusted operating income (loss) | 20,629 | 28,065 | 69,650 | 80,233 | (9,905 | ) | ||||||||||||||
Amortization of acquired intangibles | ||||||||||||||||||||
- AMS | (8,829 | ) | (12,621 | ) | (27,968 | ) | (31,464 | ) | (279 | ) | ||||||||||
- ATS | (6,127 | ) | (8,251 | ) | (19,578 | ) | (20,817 | ) | (1,413 | ) | ||||||||||
Share based compensation | ||||||||||||||||||||
- AMS | - | - | - | - | (83 | ) | ||||||||||||||
- ATS | - | - | - | - | 95 | |||||||||||||||
- Corporate | (489 | ) | (488 | ) | (1,466 | ) | (2,634 | ) | (226 | ) | ||||||||||
Restructuring charges | ||||||||||||||||||||
- AMS | - | (402 | ) | - | (402 | ) | - | |||||||||||||
- ATS | (582 | ) | (355 | ) | (2,792 | ) | (1,400 | ) | (3,778 | ) | ||||||||||
One-time lease termination costs | ||||||||||||||||||||
- ATS | - | - | - | - | (576 | ) | ||||||||||||||
Merger related expenses - Corporate | (815 | ) | (534 | ) | (3,621 | ) | (3,249 | ) | (1,319 | ) | ||||||||||
Acquired in-process R&D costs | ||||||||||||||||||||
- AMS | (1,665 | ) | - | (1,665 | ) | (15,700 | ) | - | ||||||||||||
- ATS | (626 | ) | - | (626 | ) | (8,640 | ) | - | ||||||||||||
Current period impact of acquisition related adjustments: | ||||||||||||||||||||
Inventory - AMS | - | (4,156 | ) | - | (23,817 | ) | (57 | ) | ||||||||||||
Inventory - ATS | - | (1,495 | ) | - | (15,151 | ) | - | |||||||||||||
Depreciation - AMS | (285 | ) | (293 | ) | (857 | ) | (732 | ) | - | |||||||||||
Depreciation - ATS | (629 | ) | (823 | ) | (2,043 | ) | (2,058 | ) | - | |||||||||||
Depreciation - Corporate | (55 | ) | (55 | ) | (165 | ) | (137 | ) | - | |||||||||||
Deferred revenue - ATS | (64 | ) | (576 | ) | (240 | ) | (2,235 | ) | - | |||||||||||
Company sale transaction expenses | - | (850 | ) | - | (32,459 | ) | (3,717 | ) | ||||||||||||
Operating income (loss) (GAAP) | 463 | (2,834 | ) | 8,629 | (80,662 | ) | (21,258 | ) | ||||||||||||
Interest expense | (20,566 | ) | (20,536 | ) | (63,031 | ) | (53,649 | ) | (275 | ) | ||||||||||
Other income (expense), net | (47 | ) | 1,960 | 12,366 | 3,881 | 294 | ||||||||||||||
Income (loss) from continuing operations before income taxes | $ | (20,150 | ) | $ | (21,410 | ) | $ | (42,036 | ) | $ | (130,430 | ) | $ | (21,239 | ) |
- 28 - -
Management evaluates the operating results of the two segments based upon pre-tax operating income, before costs related to restructuring, lease termination charges, amortization of acquired intangibles, share-based compensation, acquired in-process research and development costs, Company Sale Transaction expenses, merger related expenses and the impact of any acquisition related adjustments.
15. | Guarantor/Non-Guarantor Financial Information |
The following supplemental condensed consolidating financial information sets forth, on an unconsolidated basis, the balance sheets and the statements of operations, and cash flows for Aeroflex Incorporated (the “Parent Company”), the Guarantor Subsidiaries and, on a combined basis, the Non-Guarantor Subsidiaries. The supplemental condensed consolidating financial information reflects, for all fiscal periods presented, the investments of the Parent Company in the Guarantor Subsidiaries as well as the investments of the Parent Company and the Guarantor Subsidiaries in the Non-Guarantor Subsidiaries, in all cases, using the equity method. The Parent Company’s purchase price allocation adjustments, including applicable intangible assets, arising from business acquisitions have been pushed down to the applicable subsidiary columns (see Notes 3 and 4).
Condensed Consolidating Statement of Operations
For the Three Months Ended March 31, 2009
(In thousands)
Subsidiary | Subsidiary | |||||||||||||||||||
Parent | Guarantors | Non-Guarantors | Eliminations | Consolidated | ||||||||||||||||
Net sales | $ | - | $ | 100,972 | $ | 40,784 | $ | (2,317 | ) | $ | 139,439 | |||||||||
Cost of sales | - | 52,418 | 22,170 | (1,754 | ) | 72,834 | ||||||||||||||
Gross profit | - | 48,554 | 18,614 | (563 | ) | 66,605 | ||||||||||||||
Selling, general and administrative costs | 4,214 | 18,790 | 7,950 | - | 30,954 | |||||||||||||||
Research and development costs | - | 11,980 | 5,961 | - | 17,941 | |||||||||||||||
Amortization of acquired intangibles | - | 12,706 | 2,250 | - | 14,956 | |||||||||||||||
Acquired in-process R&D costs | - | 626 | 1,665 | - | 2,291 | |||||||||||||||
Operating income (loss) | (4,214 | ) | 4,452 | 788 | (563 | ) | 463 | |||||||||||||
Other income (expense): | ||||||||||||||||||||
Interest expense | (20,542 | ) | (23 | ) | (1 | ) | - | (20,566 | ) | |||||||||||
Other income (expense), net | 711 | 180 | (938 | ) | - | (47 | ) | |||||||||||||
Intercompany charges | 18,433 | (18,115 | ) | (318 | ) | - | - | |||||||||||||
Income (loss) from continuing operations before income taxes | (5,612 | ) | (13,506 | ) | (469 | ) | (563 | ) | (20,150 | ) | ||||||||||
Provision (benefit) for income taxes | (2,805 | ) | (7,207 | ) | 3,436 | 160 | (6,416 | ) | ||||||||||||
Income (loss) from continuing operations | (2,807 | ) | (6,299 | ) | (3,905 | ) | (723 | ) | (13,734 | ) | ||||||||||
Equity income (loss) of subsidiaries | (10,927 | ) | (3,439 | ) | - | 14,366 | - | |||||||||||||
Net income (loss) | $ | (13,734 | ) | $ | (9,738 | ) | $ | (3,905 | ) | $ | 13,643 | $ | (13,734 | ) |
- 29 - -
Condensed Consolidating Statement of Operations
For the Three Months Ended March 31, 2008
(In thousands)
Subsidiary | Subsidiary | |||||||||||||||||||
Parent | Guarantors | Non-Guarantors | Eliminations | Consolidated | ||||||||||||||||
Net sales | $ | - | $ | 116,183 | $ | 42,862 | $ | (1,741 | ) | $ | 157,304 | |||||||||
Cost of sales | - | 65,434 | 24,295 | (1,661 | ) | 88,068 | ||||||||||||||
Gross profit | - | 50,749 | 18,567 | (80 | ) | 69,236 | ||||||||||||||
Selling, general and administrative costs | 3,165 | 18,823 | 10,206 | - | 32,194 | |||||||||||||||
Research and development costs | - | 11,069 | 7,085 | - | 18,154 | |||||||||||||||
Amortization of acquired intangibles | - | 18,130 | 2,742 | - | 20,872 | |||||||||||||||
Company sale transaction expenses | 850 | - | - | - | 850 | |||||||||||||||
Operating income (loss) | (4,015 | ) | 2,727 | (1,466 | ) | (80 | ) | (2,834 | ) | |||||||||||
Other income (expense): | ||||||||||||||||||||
Interest expense | (20,513 | ) | (27 | ) | 4 | - | (20,536 | ) | ||||||||||||
Other income (expense), net | 706 | 27 | 1,227 | - | 1,960 | |||||||||||||||
Intercompany charges | 10,122 | (9,347 | ) | (775 | ) | - | - | |||||||||||||
Income (loss) from continuing operations before income taxes | (13,700 | ) | (6,620 | ) | (1,010 | ) | (80 | ) | (21,410 | ) | ||||||||||
Provision (benefit) for income taxes | (4,081 | ) | (1,971 | ) | 250 | (171 | ) | (5,973 | ) | |||||||||||
Income (loss) from continuing operations | (9,619 | ) | (4,649 | ) | (1,260 | ) | 91 | (15,437 | ) | |||||||||||
Loss from discontinued operations, net of taxes | - | (968 | ) | - | - | (968 | ) | |||||||||||||
Equity income (loss) of subsidiaries | (6,786 | ) | (1,110 | ) | - | 7,896 | - | |||||||||||||
Net income (loss) | $ | (16,405 | ) | $ | (6,727 | ) | $ | (1,260 | ) | $ | 7,987 | $ | (16,405 | ) |
- 30 - -
Condensed Consolidating Statement of Operations
For the Nine Months Ended March 31, 2009
(In thousands)
Subsidiary | Subsidiary | |||||||||||||||||||
Parent | Guarantors | Non-Guarantors | Eliminations | Consolidated | ||||||||||||||||
Net sales | $ | - | $ | 308,770 | $ | 133,443 | $ | (5,114 | ) | $ | 437,099 | |||||||||
Cost of sales | - | 161,170 | 73,410 | (4,604 | ) | 229,976 | ||||||||||||||
Gross profit | - | 147,600 | 60,033 | (510 | ) | 207,123 | ||||||||||||||
Selling, general and administrative costs | 14,673 | 55,120 | 26,819 | - | 96,612 | |||||||||||||||
Research and development costs | - | 34,422 | 17,623 | - | 52,045 | |||||||||||||||
Amortization of acquired intangibles | - | 40,582 | 6,964 | - | 47,546 | |||||||||||||||
Acquired in-process R&D costs | - | 626 | 1,665 | - | 2,291 | |||||||||||||||
Operating income (loss) | (14,673 | ) | 16,850 | 6,962 | (510 | ) | 8,629 | |||||||||||||
Other income (expense): | ||||||||||||||||||||
Interest expense | (62,952 | ) | (68 | ) | (11 | ) | - | (63,031 | ) | |||||||||||
Other income (expense), net | 49 | 545 | 11,772 | - | 12,366 | |||||||||||||||
Intercompany charges | 55,345 | (54,341 | ) | (1,004 | ) | - | - | |||||||||||||
Income (loss) from continuing operations before income taxes | (22,231 | ) | (37,014 | ) | 17,719 | (510 | ) | (42,036 | ) | |||||||||||
Provision (benefit) for income taxes | (8,239 | ) | (15,268 | ) | 6,139 | 70 | (17,298 | ) | ||||||||||||
Income (loss) from continuing operations | (13,992 | ) | (21,746 | ) | 11,580 | (580 | ) | (24,738 | ) | |||||||||||
Equity income (loss) of subsidiaries | (10,746 | ) | 12,452 | - | (1,706 | ) | - | |||||||||||||
Net income (loss) | $ | (24,738 | ) | $ | (9,294 | ) | $ | 11,580 | $ | (2,286 | ) | $ | (24,738 | ) |
- 31 - -
Condensed Consolidating Statement of Operations
For the Period from August 15, 2007 to March 31, 2008
(In thousands)
Subsidiary | Subsidiary | |||||||||||||||||||
Parent | Guarantors | Non-Guarantors | Eliminations | Consolidated | ||||||||||||||||
Net sales | $ | - | $ | 298,928 | $ | 124,676 | $ | (3,528 | ) | $ | 420,076 | |||||||||
Cost of sales | - | 186,333 | 76,120 | (3,501 | ) | 258,952 | ||||||||||||||
Gross profit | - | 112,595 | 48,556 | (27 | ) | 161,124 | ||||||||||||||
Selling, general and administrative costs | 11,518 | 46,075 | 26,557 | - | 84,150 | |||||||||||||||
Research and development costs | - | 28,666 | 19,890 | - | 48,556 | |||||||||||||||
Amortization of acquired intangibles | - | 45,425 | 6,856 | - | 52,281 | |||||||||||||||
Acquired in-process R&D costs | - | 21,820 | 2,520 | - | 24,340 | |||||||||||||||
Company sale transaction expenses | 32,459 | - | - | - | 32,459 | |||||||||||||||
Operating income (loss) | (43,977 | ) | (29,391 | ) | (7,267 | ) | (27 | ) | (80,662 | ) | ||||||||||
Other income (expense): | ||||||||||||||||||||
Interest expense | (53,586 | ) | (68 | ) | 5 | - | (53,649 | ) | ||||||||||||
Other income (expense), net | 1,450 | 64 | 2,367 | - | 3,881 | |||||||||||||||
Intercompany charges | 27,322 | (25,280 | ) | (2,042 | ) | - | - | |||||||||||||
Income (loss) from continuing operations before income taxes | (68,791 | ) | (54,675 | ) | (6,937 | ) | (27 | ) | (130,430 | ) | ||||||||||
Provision (benefit) for income taxes | (20,486 | ) | (16,281 | ) | 1,715 | (1,337 | ) | (36,389 | ) | |||||||||||
Income (loss) from continuing operations | (48,305 | ) | (38,394 | ) | (8,652 | ) | 1,310 | (94,041 | ) | |||||||||||
Loss from discontinued operations, net of taxes | - | (2,457 | ) | - | - | (2,457 | ) | |||||||||||||
Equity income (loss) of subsidiaries | (48,193 | ) | (8,394 | ) | - | 56,587 | - | |||||||||||||
Net income (loss) | $ | (96,498 | ) | $ | (49,245 | ) | $ | (8,652 | ) | $ | 57,897 | $ | (96,498 | ) |
- 32 - -
Condensed Consolidating Statement of Operations
For the Period from July 1, 2007 to August 14, 2007
(In thousands)
Subsidiary | Subsidiary | |||||||||||||||||||
Parent | Guarantors | Non-Guarantors | Eliminations | Consolidated | ||||||||||||||||
Net sales | $ | - | $ | 25,858 | $ | 12,809 | $ | (446 | ) | $ | 38,221 | |||||||||
Cost of sales | - | 15,066 | 8,074 | (279 | ) | 22,861 | ||||||||||||||
Gross profit | - | 10,792 | 4,735 | (167 | ) | 15,360 | ||||||||||||||
Selling, general and administrative costs | 3,892 | 7,571 | 7,568 | - | 19,031 | |||||||||||||||
Research and development costs | - | 5,526 | 6,652 | - | 12,178 | |||||||||||||||
Amortization of acquired intangibles | - | 601 | 1,091 | - | 1,692 | |||||||||||||||
Company sale transaction expenses | 3,717 | - | - | - | 3,717 | |||||||||||||||
Operating income (loss) | (7,609 | ) | (2,906 | ) | (10,576 | ) | (167 | ) | (21,258 | ) | ||||||||||
Other income (expense): | ||||||||||||||||||||
Interest expense | (261 | ) | (14 | ) | - | - | (275 | ) | ||||||||||||
Other income (expense), net | 157 | 27 | 110 | - | 294 | |||||||||||||||
Intercompany charges | 5,544 | (5,109 | ) | (435 | ) | - | - | |||||||||||||
Income (loss) from continuing operations before income taxes | (2,169 | ) | (8,002 | ) | (10,901 | ) | (167 | ) | (21,239 | ) | ||||||||||
Provision (benefit) for income taxes | (853 | ) | (3,145 | ) | (2,833 | ) | - | (6,831 | ) | |||||||||||
Income (loss) from continuing operations | (1,316 | ) | (4,857 | ) | (8,068 | ) | (167 | ) | (14,408 | ) | ||||||||||
Loss from discontinued operations, net of taxes | - | (2,508 | ) | - | - | (2,508 | ) | |||||||||||||
Equity income (loss) of subsidiaries | (15,600 | ) | (7,814 | ) | - | 23,414 | - | |||||||||||||
Net income (loss) | $ | (16,916 | ) | $ | (15,179 | ) | $ | (8,068 | ) | $ | 23,247 | $ | (16,916 | ) |
- 33 - -
Condensed Consolidating Balance Sheet
As of March 31, 2009
(In thousands)
Subsidiary | Subsidiary | |||||||||||||||||||
Parent | Guarantors | Non-Guarantors | Eliminations | Consolidated | ||||||||||||||||
Assets | ||||||||||||||||||||
Current assets: | ||||||||||||||||||||
Cash and cash equivalents | $ | 28,608 | $ | (752 | ) | $ | 26,075 | $ | - | $ | 53,931 | |||||||||
Accounts receivable, net | - | 74,123 | 39,345 | - | 113,468 | |||||||||||||||
Inventories | - | 108,576 | 30,289 | (1,011 | ) | 137,854 | ||||||||||||||
Deferred income taxes | (2,352 | ) | 23,831 | 4,257 | - | 25,736 | ||||||||||||||
Prepaid expenses and other current assets | 2,189 | 3,730 | 4,978 | - | 10,897 | |||||||||||||||
Total current assets | 28,445 | 209,508 | 104,944 | (1,011 | ) | 341,886 | ||||||||||||||
Property, plant and equipment, net | 12,893 | 65,840 | 19,440 | - | 98,173 | |||||||||||||||
Non-current marketable securities | 17,523 | - | - | - | 17,523 | |||||||||||||||
Deferred financing costs | 26,947 | - | - | - | 26,947 | |||||||||||||||
Other assets | 12,691 | 2,298 | 622 | - | 15,611 | |||||||||||||||
Intangible assets with definite lives, net | - | 261,116 | 37,478 | - | 298,594 | |||||||||||||||
Intangible assets with indefinite lives | - | 90,229 | 23,436 | - | 113,665 | |||||||||||||||
Goodwill | (10 | ) | 423,281 | 30,981 | - | 454,252 | ||||||||||||||
Total assets | $ | 98,489 | $ | 1,052,272 | $ | 216,901 | $ | (1,011 | ) | $ | 1,366,651 | |||||||||
Liabilities and Stockholder's Equity | ||||||||||||||||||||
Current liabilities: | ||||||||||||||||||||
Current portion of long-term debt | $ | 5,063 | $ | 320 | $ | - | $ | - | $ | 5,383 | ||||||||||
Accounts payable | 22 | 22,278 | 14,511 | - | 36,811 | |||||||||||||||
Deferred revenue, including advance payments | - | 18,624 | 14,107 | - | 32,731 | |||||||||||||||
Income taxes payable | - | 2,647 | 8,726 | - | 11,373 | |||||||||||||||
Accrued payroll expense | 1,360 | 18,011 | 1,608 | - | 20,979 | |||||||||||||||
Accrued expenses and other current liabilities | 15,249 | 9,976 | 9,134 | - | 34,359 | |||||||||||||||
Total current liabilities | 21,694 | 71,856 | 48,086 | - | 141,636 | |||||||||||||||
Long-term debt | 880,128 | 1,085 | - | - | 881,213 | |||||||||||||||
Deferred income taxes | (26,677 | ) | 135,557 | 14,497 | 71 | 123,448 | ||||||||||||||
Defined benefit plan obligations | 6,043 | - | - | - | 6,043 | |||||||||||||||
Other long-term liabilities | 18,452 | 434 | 4,428 | - | 23,314 | |||||||||||||||
Intercompany investment | (270,660 | ) | 30,964 | 239,696 | - | - | ||||||||||||||
Intercompany receivable/payable | (859,390 | ) | 892,486 | (32,613 | ) | (483 | ) | - | ||||||||||||
Total liabilities | (230,410 | ) | 1,132,382 | 274,094 | (412 | ) | 1,175,654 | |||||||||||||
Stockholder's equity | 328,899 | (80,110 | ) | (57,193 | ) | (599 | ) | 190,997 | ||||||||||||
Total liabilities and stockholder's equity | $ | 98,489 | $ | 1,052,272 | $ | 216,901 | $ | (1,011 | ) | $ | 1,366,651 |
- 34 - -
Condensed Consolidating Balance Sheet
As of June 30, 2008
(In thousands)
Subsidiary | Subsidiary | |||||||||||||||||||
Parent | Guarantors | Non-Guarantors | Eliminations | Consolidated | ||||||||||||||||
Assets | ||||||||||||||||||||
Current assets: | ||||||||||||||||||||
Cash and cash equivalents | $ | 39,285 | $ | (2,379 | ) | $ | 17,243 | $ | - | $ | 54,149 | |||||||||
Accounts receivable, net | - | 90,343 | 57,640 | - | 147,983 | |||||||||||||||
Inventories | - | 91,856 | 43,537 | (502 | ) | 134,891 | ||||||||||||||
Deferred income taxes | (2,352 | ) | 23,539 | 5,852 | - | 27,039 | ||||||||||||||
Prepaid expenses and other current assets | 2,464 | 2,616 | 7,104 | - | 12,184 | |||||||||||||||
Total current assets | 39,397 | 205,975 | 131,376 | (502 | ) | 376,246 | ||||||||||||||
Property, plant and equipment, net | 13,406 | 63,964 | 27,279 | - | 104,649 | |||||||||||||||
Non-current marketable securities | 19,960 | - | - | - | 19,960 | |||||||||||||||
Deferred financing costs | 30,185 | - | - | - | 30,185 | |||||||||||||||
Other assets | 16,480 | 2,474 | (394 | ) | - | 18,560 | ||||||||||||||
Intangible assets with definite lives, net | - | 297,408 | 47,458 | - | 344,866 | |||||||||||||||
Intangible assets with indefinite lives | - | 90,229 | 33,149 | - | 123,378 | |||||||||||||||
Goodwill | - | 435,570 | 25,101 | 484 | 461,155 | |||||||||||||||
Total assets | $ | 119,428 | $ | 1,095,620 | $ | 263,969 | $ | (18 | ) | $ | 1,478,999 | |||||||||
Liabilities and Stockholder's Equity | ||||||||||||||||||||
Current liabilities: | ||||||||||||||||||||
Current portion of long-term debt | $ | 5,250 | $ | 324 | $ | - | $ | - | $ | 5,574 | ||||||||||
Accounts payable | 554 | 19,882 | 18,946 | - | 39,382 | |||||||||||||||
Deferred revenue, including advance payments | - | 8,621 | 18,523 | - | 27,144 | |||||||||||||||
Income taxes payable | 409 | - | 1,527 | - | 1,936 | |||||||||||||||
Accrued payroll expense | 2,106 | 18,200 | 4,219 | - | 24,525 | |||||||||||||||
Accrued expenses and other current liabilities | 31,205 | 12,272 | 13,353 | - | 56,830 | |||||||||||||||
Total current liabilities | 39,524 | 59,299 | 56,568 | - | 155,391 | |||||||||||||||
Long-term debt | 872,152 | 1,085 | - | - | 873,237 | |||||||||||||||
Deferred income taxes | (12,254 | ) | 150,400 | 21,311 | - | 159,457 | ||||||||||||||
Defined benefit plan obligations | 6,263 | - | - | - | 6,263 | |||||||||||||||
Other long-term liabilities | 1,368 | 487 | 6,148 | - | 8,003 | |||||||||||||||
Intercompany investment | (248,051 | ) | 2,944 | 245,107 | - | - | ||||||||||||||
Intercompany receivable/payable | (895,004 | ) | 953,623 | (58,619 | ) | - | - | |||||||||||||
Total liabilities | (236,002 | ) | 1,167,838 | 270,515 | - | 1,202,351 | ||||||||||||||
Stockholder's equity | 355,430 | (72,218 | ) | (6,546 | ) | (18 | ) | 276,648 | ||||||||||||
Total liabilities and stockholder's equity | $ | 119,428 | $ | 1,095,620 | $ | 263,969 | $ | (18 | ) | $ | 1,478,999 |
- 35 - -
Condensed Consolidating Statement of Cash Flows
For the Nine Months Ended March 31, 2009
(In thousands)
Non- | ||||||||||||||||||||
Guarantor | Guarantor | Consolidating | ||||||||||||||||||
Parent | Subsidiaries | Subsidiaries | Adjustments | Consolidated | ||||||||||||||||
Cash flows from operating activities: | ||||||||||||||||||||
Net income (loss) | $ | (24,738 | ) | $ | (9,294 | ) | $ | 11,580 | $ | (2,286 | ) | $ | (24,738 | ) | ||||||
Changes in operating assets and liabilities and non-cash items, included in net earnings (loss) | 26,373 | 18,186 | 12,886 | 2,286 | 59,731 | |||||||||||||||
Net cash provided by (used in) operating activities | 1,635 | 8,892 | 24,466 | - | 34,993 | |||||||||||||||
Cash flows from investing activities: | ||||||||||||||||||||
Payment for purchase of businesses, net of cash acquired | (7,832 | ) | - | - | - | (7,832 | ) | |||||||||||||
Capital expenditures | (11 | ) | (8,406 | ) | (4,541 | ) | - | (12,958 | ) | |||||||||||
Proceeds from the sale of property, plant and equipment | - | 1,145 | 214 | - | 1,359 | |||||||||||||||
Other, net | (4 | ) | - | - | - | (4 | ) | |||||||||||||
Net cash provided by (used in) investing activities | (7,847 | ) | (7,261 | ) | (4,327 | ) | - | (19,435 | ) | |||||||||||
Cash flows from financing activities: | ||||||||||||||||||||
Debt repayments | (4,125 | ) | (4 | ) | - | - | (4,129 | ) | ||||||||||||
Debt financing costs | (340 | ) | - | - | - | (340 | ) | |||||||||||||
Net cash provided by (used in) financing activities | (4,465 | ) | (4 | ) | - | - | (4,469 | ) | ||||||||||||
Effect of exchange rate changes on cash and cash equivalents | - | - | (11,307 | ) | - | (11,307 | ) | |||||||||||||
Net increase (decrease) in cash and cash equivalents | (10,677 | ) | 1,627 | 8,832 | - | (218 | ) | |||||||||||||
Cash and cash equivalents at beginning of period | 39,285 | (2,379 | ) | 17,243 | - | 54,149 | ||||||||||||||
Cash and cash equivalents at end of period | $ | 28,608 | $ | (752 | ) | $ | 26,075 | $ | - | $ | 53,931 |
- 36 - -
Condensed Consolidating Statement of Cash Flows
For the Period from August 15, 2007 to March 31, 2008
(In thousands)
Non- | ||||||||||||||||||||
Guarantor | Guarantor | Consolidating | ||||||||||||||||||
Parent | Subsidiaries | Subsidiaries | Adjustments | Consolidated | ||||||||||||||||
Cash flows from operating activities: | ||||||||||||||||||||
Net income (loss) | $ | (96,498 | ) | $ | (49,245 | ) | $ | (8,652 | ) | $ | 57,897 | $ | (96,498 | ) | ||||||
Loss from discontinued operations, net of tax | - | 2,457 | - | - | 2,457 | |||||||||||||||
Income (loss) from continuing operations | (96,498 | ) | (46,788 | ) | (8,652 | ) | 57,897 | (94,041 | ) | |||||||||||
Changes in operating assets and liabilities and non cash items, included in net income (loss) | 45,362 | 57,304 | 22,585 | (57,897 | ) | 67,354 | ||||||||||||||
Net cash provided by (used in) continuing operations | (51,136 | ) | 10,516 | 13,933 | - | (26,687 | ) | |||||||||||||
Net cash provided by (used in) discontinued operations | - | (3,133 | ) | - | - | (3,133 | ) | |||||||||||||
Net cash provided by (used in) operating activities | (51,136 | ) | 7,383 | 13,933 | - | (29,820 | ) | |||||||||||||
Cash flows from investing activities: | ||||||||||||||||||||
Acquisition of predecessor entity, net of cash acquired | (1,128,915 | ) | (2,593 | ) | 13,215 | - | (1,118,293 | ) | ||||||||||||
Payment for purchase of businesses, net of cash acquired | 1,522 | - | - | - | 1,522 | |||||||||||||||
Capital expenditures | (258 | ) | (6,380 | ) | (1,890 | ) | - | (8,528 | ) | |||||||||||
Proceeds from the sale of property, plant and equipment | - | 15 | 15 | - | 30 | |||||||||||||||
Purchase of marketable securities | (631,805 | ) | - | - | - | (631,805 | ) | |||||||||||||
Proceeds from sale of marketable securities | 599,977 | - | - | - | 599,977 | |||||||||||||||
Net cash provided by (used in) investing activities of continuing operations | (1,159,479 | ) | (8,958 | ) | 11,340 | - | (1,157,097 | ) | ||||||||||||
Net cash provided by (used in) discontinued operations | - | (32 | ) | - | - | (32 | ) | |||||||||||||
Net cash provided by (used in) investing activities | (1,159,479 | ) | (8,990 | ) | 11,340 | - | (1,157,129 | ) | ||||||||||||
Cash flows from financing activities: | ||||||||||||||||||||
Proceeds from issuance of common stock | 378,350 | - | - | - | 378,350 | |||||||||||||||
Borrowings under debt agreements | 870,000 | - | - | - | 870,000 | |||||||||||||||
Debt repayments | (4,434 | ) | (19 | ) | - | - | (4,453 | ) | ||||||||||||
Debt financing costs | (27,436 | ) | - | - | - | (27,436 | ) | |||||||||||||
Amounts paid for withholding taxes on stock option exercises | (14,142 | ) | - | - | - | (14,142 | ) | |||||||||||||
Witholding taxes collected for stock option exercises | 14,142 | - | - | - | 14,142 | |||||||||||||||
Net cash provided by (used in) financing activities of continuing operations | 1,216,480 | (19 | ) | - | - | 1,216,461 | ||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | - | - | (2,305 | ) | - | (2,305 | ) | |||||||||||||
Net increase (decrease) in cash and cash equivalents | 5,865 | (1,626 | ) | 22,968 | - | 27,207 | ||||||||||||||
Cash and cash equivalents at beginning of period | - | - | - | - | - | |||||||||||||||
Cash and cash equivalents at end of period | $ | 5,865 | $ | (1,626 | ) | $ | 22,968 | $ | - | $ | 27,207 |
- 37 - -
Condensed Consolidating Statement of Cash Flows
For the Period from July 1, 2007 to August 14, 2007
(In thousands)
Non- | ||||||||||||||||||||
Guarantor | Guarantor | Consolidating | ||||||||||||||||||
Parent | Subsidiaries | Subsidiaries | Adjustments | Consolidated | ||||||||||||||||
Cash flows from operating activities: | ||||||||||||||||||||
Net income (loss) | $ | (16,916 | ) | $ | (15,179 | ) | $ | (8,068 | ) | $ | 23,247 | $ | (16,916 | ) | ||||||
Loss from discontinued operations, net of tax | - | 2,508 | - | - | 2,508 | |||||||||||||||
Income (loss) from continuing operations | (16,916 | ) | (12,671 | ) | (8,068 | ) | 23,247 | (14,408 | ) | |||||||||||
Changes in operating assets and liabilities and non cash items, included in net income (loss) | 23,110 | 12,708 | 13,591 | (23,247 | ) | 26,162 | ||||||||||||||
Net cash provided by (used in) continuing operations | 6,194 | 37 | 5,523 | - | 11,754 | |||||||||||||||
Net cash provided by (used in) discontinued operations | - | (461 | ) | - | - | (461 | ) | |||||||||||||
Net cash provided by (used in) operating activities | 6,194 | (424 | ) | 5,523 | - | 11,293 | ||||||||||||||
Cash flows from investing activities: | ||||||||||||||||||||
Capital expenditures | (249 | ) | (587 | ) | (252 | ) | - | (1,088 | ) | |||||||||||
Purchase of marketable securities | (53,828 | ) | - | - | - | (53,828 | ) | |||||||||||||
Proceeds from sale of marketable securities | 63,328 | - | - | - | 63,328 | |||||||||||||||
Net cash provided by (used in) investing activities of continuing operations | 9,251 | (587 | ) | (252 | ) | - | 8,412 | |||||||||||||
Net cash provided by (used in) discontinued operations | - | (6 | ) | - | - | (6 | ) | |||||||||||||
Net cash provided by (used in) investing activities | 9,251 | (593 | ) | (252 | ) | - | 8,406 | |||||||||||||
Cash flows from financing activities: | ||||||||||||||||||||
Debt repayments | (26 | ) | (3 | ) | - | - | (29 | ) | ||||||||||||
Debt financing costs | (477 | ) | - | - | - | (477 | ) | |||||||||||||
Excess tax benefits from share based compensation arrangements | 12,542 | - | - | - | 12,542 | |||||||||||||||
Proceeds from the exercise of stock options and warrants | 583 | - | - | - | 583 | |||||||||||||||
Amounts paid for withholding taxes on stock option exercises | (56 | ) | - | - | - | (56 | ) | |||||||||||||
Withholding taxes collected for stock option exercises | 56 | - | - | - | 56 | |||||||||||||||
Net cash provided by (used in) financing activities of continuing operations | 12,622 | (3 | ) | - | - | 12,619 | ||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | - | - | 178 | - | 178 | |||||||||||||||
Net increase (decrease) in cash and cash equivalents | 28,067 | (1,020 | ) | 5,449 | - | 32,496 | ||||||||||||||
Cash and cash equivalents at beginning of period | 6,807 | (1,573 | ) | 7,766 | - | 13,000 | ||||||||||||||
Cash and cash equivalents at end of period | $ | 34,874 | $ | (2,593 | ) | $ | 13,215 | $ | - | $ | 45,496 |
- 38 - -
ITEM 2 - | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
Overview
We are a leading provider of highly specialized microelectronics and test and measurement equipment, primarily to the global aerospace and defense and broadband communications markets. We also design application specific integrated circuits (“ASICs”) for CT scan equipment for the medical industry. Founded in 1937, we have developed a substantial intellectual property portfolio that includes more than 150 patents, extensive know-how, years of collaborative research and development with our customers and a demonstrated history in space, validating the high quality performance of our products. We believe that the combination of our leading market positions, complementary portfolio of products, years of experience and engineering capabilities provides us with a competitive advantage and enables us to deliver high performance, high value products to our customers.
The Acquisition
On August 15, 2007, AX Acquisition and its parent consummated a merger with Aeroflex Incorporated. At the effective time of the merger, AX Acquisition was merged with and into Aeroflex Incorporated. Aeroflex Incorporated was the surviving corporation in the merger and became a wholly-owned subsidiary of the parent.
The acquisition was funded by:
· | equity investments in the parent of approximately $378.4 million by affiliates of, or funds managed by, The Veritas Capital Fund III, L.P., Golden Gate Private Equity, Inc. and GS Direct, L.L.C. (the “Sponsors”) and certain members of our management; |
· | borrowings under a senior secured credit facility, consisting of $525.0 million under our term loan facility; |
· | borrowings under an exchangeable senior unsecured credit facility, consisting of a $225.0 million term loan facility; and |
· | borrowings under an exchangeable senior subordinated unsecured credit facility, consisting of a $120.0 million term loan facility. |
On September 21, 2007, we entered into a $120.0 million senior subordinated unsecured credit facility to refinance the $120.0 million exchangeable senior subordinated unsecured credit facility. On August 7, 2008, we entered into a $225.0 million senior unsecured credit facility to refinance the $225.0 million exchangeable senior unsecured credit facility.
Results of Operations
Refer to Notes 1 and 3 to our consolidated financial statements for details concerning the Company’s August 15, 2007 acquisition by affiliates of or funds managed by the Sponsors and certain members of our management and the basis upon which such consolidated financial statements are presented. For comparative purposes in this Management’s Discussion and Analysis of Financial Condition and Results of Operations, we combined the Predecessor period from July 1, 2007 to August 14, 2007 with the Successor period from August 15, 2007 to March 31, 2008 to form the nine months ended March 31, 2008. This combination is not a GAAP presentation. However, we believe this presentation is useful to the reader as a comparison to the Successor period for the nine months ended March 31, 2009.
- 39 - -
The following table sets forth our historical results of operations as a percentage of net sales for the periods indicated below:
Non-GAAP | ||||||||||||||||||||||||
combined | ||||||||||||||||||||||||
Predecessor | ||||||||||||||||||||||||
Successor | Successor | Successor | and Successor | Successor | Predecessor | |||||||||||||||||||
Period | Period | |||||||||||||||||||||||
Three | Three | Nine | Nine | August 15, | July 1, | |||||||||||||||||||
Months | Months | Months | Months | 2007 | 2007 | |||||||||||||||||||
Ended | Ended | Ended | Ended | through | through | |||||||||||||||||||
March 31, | March 31, | March 31, | March 31, | March 31, | August 14, | |||||||||||||||||||
2009 | 2008 | 2009 | 2008 | 2008 | 2007 | |||||||||||||||||||
Net sales | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | ||||||||||||
Costs of sales | 52.2 | 56.0 | 52.6 | 61.5 | 61.6 | 59.8 | ||||||||||||||||||
Gross profit | 47.8 | 44.0 | 47.4 | 38.5 | 38.4 | 40.2 | ||||||||||||||||||
Operating expenses: | ||||||||||||||||||||||||
Selling, general and administrative costs | 22.2 | 20.5 | 22.1 | 22.5 | 20.0 | 49.8 | ||||||||||||||||||
Research and development costs | 12.9 | 11.5 | 11.9 | 13.2 | 11.6 | 31.9 | ||||||||||||||||||
Amortization of acquired intangibles | 10.7 | 13.3 | 10.9 | 11.8 | 12.5 | 4.4 | ||||||||||||||||||
Acquired in-process research and development costs | 1.7 | - | - | 5.3 | 5.8 | - | ||||||||||||||||||
Company sale transaction expenses | - | 0.5 | 0.5 | 7.9 | 7.7 | 9.7 | ||||||||||||||||||
Total operating expenses | 47.5 | 45.8 | 45.4 | 60.7 | 57.6 | 95.8 | ||||||||||||||||||
Operating income (loss) | 0.3 | (1.8 | ) | 2.0 | (22.2 | ) | (19.2 | ) | (55.6 | ) | ||||||||||||||
Interest expense | (14.8 | ) | (13.1 | ) | (14.4 | ) | (11.8 | ) | (12.8 | ) | - | |||||||||||||
Other income (expense), net | - | 1.3 | 2.8 | 0.9 | 0.9 | - | ||||||||||||||||||
(14.8 | ) | (11.8 | ) | (11.6 | ) | (10.9 | ) | (11.9 | ) | - | ||||||||||||||
Income (loss) from continuing operations before income taxes | (14.5 | ) | (13.6 | ) | (9.6 | ) | (33.1 | ) | (31.1 | ) | (55.6 | ) | ||||||||||||
Provision (benefit) for income taxes | (4.6 | ) | (3.8 | ) | (3.9 | ) | (9.4 | ) | (8.7 | ) | (17.9 | ) | ||||||||||||
Income (loss) from continuing operations | (9.9 | ) | (9.8 | ) | (5.7 | ) | (23.7 | ) | (22.4 | ) | (37.7 | ) | ||||||||||||
Discontinued operations | - | (0.6 | ) | - | (1.1 | ) | (0.6 | ) | (6.6 | ) | ||||||||||||||
Net income (loss) | (9.9 | )% | (10.4 | )% | (5.7 | )% | (24.8 | )% | (23.0 | )% | (44.3 | )% |
Management evaluates the operating results of the Company’s two segments based upon pre-tax operating income, before costs related to restructuring, lease termination charges, amortization of acquired intangibles, share-based compensation, acquired in-process research and development costs, Company Sale Transaction expenses, merger related expenses and the impact of any acquisition related adjustments.
- 40 - -
The following table sets forth our net sales and adjusted operating income by business segment and reconciles Adjusted Operating Income (Loss) to Income (Loss) From Continuing Operations Before Income Taxes for the periods indicated:
Non-GAAP | ||||||||||||||||||||||||
Combined | ||||||||||||||||||||||||
Predecessor | ||||||||||||||||||||||||
Successor | Successor | Successor | and Successor | Successor | Predecessor | |||||||||||||||||||
Three Months | Three Months | Nine Months | Nine Months | August 15, 2007 | ||||||||||||||||||||
Ended | Ended | Ended | Ended | through | July 1, 2007 | |||||||||||||||||||
March 31, | March 31, | March 31, | March 31, | March 31, | to August 14, | |||||||||||||||||||
2009 | 2008 | 2009 | 2008 | 2008 | 2007 | |||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||
Net sales: | ||||||||||||||||||||||||
Microelectronic solutions ("AMS") | $ | 70,232 | $ | 77,380 | $ | 208,564 | $ | 216,296 | $ | 197,279 | $ | 19,017 | ||||||||||||
Test solutions ("ATS") | 69,207 | 79,924 | 228,535 | 242,001 | 222,797 | 19,204 | ||||||||||||||||||
Net sales | $ | 139,439 | $ | 157,304 | $ | 437,099 | $ | 458,297 | $ | 420,076 | $ | 38,221 | ||||||||||||
Segment adjusted operating income: | ||||||||||||||||||||||||
- AMS | $ | 14,783 | $ | 19,143 | $ | 44,767 | $ | 51,387 | $ | 51,363 | $ | 24 | ||||||||||||
- ATS | 8,700 | 11,010 | 34,304 | 26,785 | 34,367 | (7,582 | ) | |||||||||||||||||
- General corporate expense | (2,854 | ) | (2,088 | ) | (9,421 | ) | (7,844 | ) | (5,497 | ) | (2,347 | ) | ||||||||||||
Adjusted operating income (loss) | 20,629 | 28,065 | 69,650 | 70,328 | 80,233 | (9,905 | ) | |||||||||||||||||
Amortization of acquired intangibles | ||||||||||||||||||||||||
- AMS | (8,829 | ) | (12,621 | ) | (27,968 | ) | (31,743 | ) | (31,464 | ) | (279 | ) | ||||||||||||
- ATS | (6,127 | ) | (8,251 | ) | (19,578 | ) | (22,230 | ) | (20,817 | ) | (1,413 | ) | ||||||||||||
Share based compensation | ||||||||||||||||||||||||
- AMS | - | - | - | (83 | ) | - | (83 | ) | ||||||||||||||||
- ATS | - | - | - | 95 | - | 95 | ||||||||||||||||||
- Corporate | (489 | ) | (488 | ) | (1,466 | ) | (2,860 | ) | (2,634 | ) | (226 | ) | ||||||||||||
Restructuring charges | ||||||||||||||||||||||||
- AMS | - | (402 | ) | - | (402 | ) | (402 | ) | - | |||||||||||||||
- ATS | (582 | ) | (355 | ) | (2,792 | ) | (5,178 | ) | (1,400 | ) | (3,778 | ) | ||||||||||||
One-time lease termination costs | ||||||||||||||||||||||||
- ATS | - | - | - | (576 | ) | - | (576 | ) | ||||||||||||||||
Merger related expenses - Corporate | (815 | ) | (534 | ) | (3,621 | ) | (4,568 | ) | (3,249 | ) | (1,319 | ) | ||||||||||||
Acquired in-process R&D costs | ||||||||||||||||||||||||
- AMS | (1,665 | ) | - | (1,665 | ) | (15,700 | ) | (15,700 | ) | - | ||||||||||||||
- ATS | (626 | ) | - | (626 | ) | (8,640 | ) | (8,640 | ) | - | ||||||||||||||
Current period impact of acquisition related adjustments: | ||||||||||||||||||||||||
Inventory - AMS | - | (4,156 | ) | - | (23,874 | ) | (23,817 | ) | (57 | ) | ||||||||||||||
Inventory - ATS | - | (1,495 | ) | - | (15,151 | ) | (15,151 | ) | - | |||||||||||||||
Depreciation - AMS | (285 | ) | (293 | ) | (857 | ) | (732 | ) | (732 | ) | - | |||||||||||||
Depreciation - ATS | (629 | ) | (823 | ) | (2,043 | ) | (2,058 | ) | (2,058 | ) | - | |||||||||||||
Depreciation - Corporate | (55 | ) | (55 | ) | (165 | ) | (137 | ) | (137 | ) | - | |||||||||||||
Deferred revenue - ATS | (64 | ) | (576 | ) | (240 | ) | (2,235 | ) | (2,235 | ) | - | |||||||||||||
Company sale transaction expenses | - | (850 | ) | - | (36,176 | ) | (32,459 | ) | (3,717 | ) | ||||||||||||||
Operating income (loss) (GAAP) | 463 | (2,834 | ) | 8,629 | (101,920 | ) | (80,662 | ) | (21,258 | ) | ||||||||||||||
Interest expense | (20,566 | ) | (20,536 | ) | (63,031 | ) | (53,924 | ) | (53,649 | ) | (275 | ) | ||||||||||||
Other income (expense), net | (47 | ) | 1,960 | 12,366 | 4,175 | 3,881 | 294 | |||||||||||||||||
Income (loss) from continuing operations before income taxes | $ | (20,150 | ) | $ | (21,410 | ) | $ | (42,036 | ) | $ | (151,669 | ) | $ | (130,430 | ) | $ | (21,239 | ) |
- 41 - -
Three Months Ended March 31, 2009 Compared to Three Months Ended March 31, 2008
Net Sales. Net sales decreased 11% to $139.4 million for the three months ended March 31, 2009 from $157.3 million for the three months ended March 31, 2008.
Net sales in the microelectronic solutions (“AMS”) segment decreased 9% to $70.2 million for the three months ended March 31, 2009 from $77.4 million for the three months ended March 31, 2008 primarily due to a reduction in sales of components due to a general slowdown in the market combined with a demand surge experienced in the prior year that was not repeated in the current year. This reduction is partially offset by an increase in sales volume of integrated circuits combined with additional sales from our acquisition of Gaisler in June 2008 ($2.0 million). Net sales in the test solutions (“ATS”) segment decreased 13% to $69.2 million in 2009 from $79.9 million in 2008. The change in foreign currency exchange rates has negatively impacted our U.K. sales by approximately $11 million. Excluding the impact of foreign currency exchange rates, sales for the three months ended March 31, 2009 increased $300,000 as compared to the three months ended March 31, 2008. Increases in sales of wireless products were offset by reductions in sales of radio test sets and synthetic test products. The period ended March 31, 2009 was impacted by a purchase accounting adjustment to deferred revenue which reduced sales by $64,000; while the period ended March 31, 2008, was impacted by a purchase accounting adjustment to deferred revenue which reduced sales by $576,000.
Gross Profit. Gross profit equals net sales less cost of sales. Cost of sales includes materials, direct labor, amortization of capitalized software development costs and overhead expenses such as engineering labor, fringe benefits, depreciation, allocable occupancy costs and manufacturing supplies.
On a consolidated basis, gross margin was 47.8% for the three months ended March 31, 2009 and 44.0% for the three months ended March 31, 2008. For the three months ended March 31, 2008, gross margin was adversely affected by purchase accounting adjustments aggregating $6.8 million which (i) increased cost of sales in the 2008 period for the increase in the recorded value of the Company’s Sale Transaction date inventories by $5.7 million to eliminate manufacturing profits inherent in the inventories at that date; (ii) increased depreciation expense by $542,000 due to acquisition date fair value adjustments and (iii) reduced sales for the quarter by $576,000 related to eliminating selling profits inherent in certain deferred revenues. In 2009, gross margin was adversely affected by (i) increased depreciation expense of $475,000 related to acquisition date fair value adjustments and (ii) reduced sales for the quarter of $64,000 related to eliminating selling profits inherent in certain acquisition date deferred revenues. Ignoring the purchase accounting adjustments, gross margin was 48.1% for both the period ended March 31, 2009 and the period ended March 31, 2008.
Three Months | Gross Profit | |||||||||||||||||||||||
Ended | ||||||||||||||||||||||||
March 31, | % of | % of | % of | |||||||||||||||||||||
(In thousands) | AMS | sales | ATS | sales | Total | sales | ||||||||||||||||||
2009 | $ | 33,095 | 47.1 | % | $ | 33,510 | 48.4 | % | $ | 66,605 | 47.8 | % | ||||||||||||
2008 | $ | 32,487 | 42.0 | % | $ | 36,749 | 46.0 | % | $ | 69,236 | 44.0 | % |
Gross margins in the AMS segment were 47.1% in 2009 and 42.0% in 2008. Gross profit was negatively impacted by purchase accounting adjustments of $198,000 in 2009 and $4.4 million in 2008. Ignoring the purchase accounting adjustments, gross margins were 47.4% in 2009 and 47.6% in 2008.
Gross margins in the ATS segment were 48.4% in 2009 and 46.0% in 2008. Gross profit was negatively impacted by purchase accounting adjustments of $340,000 versus $2.4 million in 2008. Ignoring the purchase accounting adjustments, gross margins were 48.9% in 2009 and 48.6% in 2008.
- 42 - -
Selling, General and Administrative Costs. Selling, general and administrative (“SG&A”) costs include sales, office and management salaries, fringe benefits, commissions, insurance and professional fees, as well as, merger related expenses. On a consolidated basis SG&A costs decreased $1.2 million, yet increased 170 basis points as a percentage of sales from the quarter ended March 31, 2008 to the quarter ended March 31, 2009. Excluding merger related expenses ($815,000 in 2009 and $534,000 in 2008), stock compensation costs ($489,000 in 2009 and $488,000 in 2008), acquisition related depreciation expense ($276,000 in 2009 and $364,000 in 2008) and restructuring costs ($107,000 in 2009 and $265,000 in 2008) SG&A was $29.3 million in 2009 and $30.5 million in 2008 and increased 170 basis points as a percentage of sales.
Three Months | Selling, General and Administrative Costs | |||||||||||||||||||||||||||
Ended | ||||||||||||||||||||||||||||
March 31, | % of | % of | % of | |||||||||||||||||||||||||
(In thousands) | AMS | sales | ATS | sales | Corporate | Total | sales | |||||||||||||||||||||
2009 | $ | 11,019 | 15.7 | % | $ | 15,721 | 22.7 | % | $ | 4,214 | $ | 30,954 | 22.2 | % | ||||||||||||||
2008 | $ | 10,650 | 13.8 | % | $ | 18,379 | 23.0 | % | $ | 3,165 | $ | 32,194 | 20.5 | % |
Selling, general and administrative costs increased $369,000, or 3%, in the AMS segment. Selling, general and administrative costs decreased $2.7 million, or 14%, in the ATS segment largely due to general cost savings and the benefits of restructuring activities and the related closing of the Burnham facility.
Corporate general and administrative expenses increased $1.0 million primarily due to increased professional fees related to acquisition investigations and SEC filings for debt refinancing.
Selling, general and administrative expenses increased 190 basis points, as a percentage of sales, for AMS and decreased 30 basis points for ATS. Corporate general and administrative expenses increased 100 basis points as a percentage of consolidated sales. Excluding merger related expenses, Corporate SG&A expenses increased 75 basis points.
Research and Development Costs. Research and development costs include materials, engineering labor and allocated overhead. On a consolidated basis, research and development expenses decreased $213,000, yet increased 140 basis points as a percentage of sales.
Three Months | Research and Development Costs | |||||||||||||||||||||||
Ended | ||||||||||||||||||||||||
March 31, | % of | % of | % of | |||||||||||||||||||||
(In thousands) | AMS | sales | ATS | sales | Total | sales | ||||||||||||||||||
2009 | $ | 7,579 | 10.8 | % | $ | 10,362 | 15.0 | % | $ | 17,941 | 12.9 | % | ||||||||||||
2008 | $ | 7,544 | 9.7 | % | $ | 10,610 | 13.3 | % | $ | 18,154 | 11.5 | % |
AMS segment self-funded research and development costs increased $35,000, resulting from an increase in integrated circuit projects partially offset by a reduction in microelectronic module projects. As a percentage of sales, research and development costs increased 110 basis points. Restructuring charges included in R&D were $35,000 in 2008. There were no comparable charges in 2009.
ATS segment self-funded research and development costs decreased $248,000, or 2%, as restructuring charges included in R&D were $80,000 in 2009 and $352,000 in 2008.
- 43 - -
Restructuring Costs. The AMS segment incurred restructuring costs of $402,000 in the three months ended March 31, 2008 ($107,000 in cost of sales, $260,000 in SG&A and 35,000 in R&D) related to severance for personnel reductions within our Whippany, New Jersey components manufacturing facility. The ATS segment incurred restructuring costs of $582,000 in 2009 ($395,000 in cost of sales, $107,000 in SG&A and 80,000 in R&D) related to further consolidation and reorganization efforts primarily in our U.K. operations and $355,000 in 2008 which was also related to consolidation and reorganization efforts in our U.K. operations, primarily in R&D.
Amortization of Acquired Intangibles. Amortization of acquired intangibles decreased $5.9 million in 2009 largely due to the impact of the change in foreign currency exchange rates, combined with the completion of amortization of acquired backlog recorded in the Merger. Amortization for the AMS segment decreased $3.8 million and the ATS segment decreased $2.1 million.
Other Income (Expense). Interest expense increased $30,000 to $20.6 million in 2009. Other income (expense) of $(47,000) for the three months ended March 31, 2009 consisted primarily of $(669,000) of foreign currency transaction losses and $622,000 of interest income and other miscellaneous income, net. Other income (expense) of $2.0 million for the three months ended March 31, 2008 consisted primarily of $820,000 of foreign currency transaction gains, $582,000 of interest income and $560,000 of other miscellaneous income.
Provision for Income Taxes. The income tax benefit was $6.4 million for the three months ended March 31, 2009, an effective income tax rate of 31.8%. We had an income tax benefit of $6.0 million, an effective income tax rate of 27.9% for the three months ended March 31, 2008. The effective income tax rate for the two periods differed from the amount computed by applying the U.S. Federal income tax rate to income before income taxes primarily due to foreign, state and local income taxes and for 2008, non-deductible merger expenses. We paid income taxes of $597,000 in the three months ended March 31, 2009 and $3.5 million in the three months ended March 31, 2008.
Income (loss) from Continuing Operations. The loss from continuing operations was $13.7 million for the three months ended March 31, 2009 and $15.4 million for the three months ended March 31, 2008.
Nine Months Ended March 31, 2009 Compared to Nine Months Ended March 31, 2008
Net Sales. Net sales decreased 5% to $437.1 million for the nine months ended March 31, 2009 from $458.3 million for the nine months ended March 31, 2008.
Net sales in the microelectronic solutions (“AMS”) segment decreased 4% to $208.6 million for the nine months ended March 31, 2009 from $216.3 million for the nine months ended March 31, 2008 primarily due to a reduction in sales volume of components and microelectronic modules, offset by increases in integrated circuits and motion control products combined with additional sales from our acquisition of Gaisler in June 2008 ($4.4 million). Net sales in the test solutions (“ATS”) segment decreased 6% to $228.5 million in 2009 from $242.0 million in 2008. The change in foreign currency exchange rates has negatively impacted U.K. sales by approximately $20 million. Excluding the impact of foreign currency exchange rates, sales for the nine months ended March 31, 2009 increased approximately $7 million as compared to the nine months ended March 31, 2008 primarily due to an increase in sales volume of wireless products, offset by a reduction in sales of radio test and synthetic products. The period ended March 31, 2009 was impacted by a purchase accounting adjustment to deferred revenue which reduced sales by $240,000; while the period ended March 31, 2008 was impacted by a purchase accounting adjustment to deferred revenue which reduced sales by $2.2 million.
- 44 - -
Gross Profit. On a consolidated basis, gross margin was 47.4% for the nine months ended March 31, 2009 and 38.5% for the nine months ended March 31, 2008. In 2008, gross margin was adversely affected by purchase accounting adjustments aggregating $42.6 million which (i) increased cost of sales in the 2008 period for the increase in the recorded value of the Company’s Sale Transaction date inventories by $39.0 million to eliminate manufacturing profits inherent in the inventories at that date; (ii) increased depreciation expense by $1.4 million due to acquisition date fair value adjustments and (iii) reduced sales for the nine months by $2.2 million related to eliminating selling profits inherent in certain acquisition date deferred revenues. In 2009, gross margin was adversely affected by (i) increased depreciation expense of $1.5 million related to acquisition date fair value adjustments and (ii) reduced sales for the nine months by $240,000 related to eliminating profits inherent in certain acquisition date deferred revenue. Ignoring the purchase accounting adjustments, gross margin was 47.8% for the period ended March 31, 2009 and 47.6% for the period ended March 31, 2008.
Nine Months | Gross Profit | |||||||||||||||||||||||
Ended | ||||||||||||||||||||||||
March 31, | % of | % of | % of | |||||||||||||||||||||
(In thousands) | AMS | sales | ATS | sales | Total | sales | ||||||||||||||||||
2009 | $ | 98,191 | 47.1 | % | $ | 108,932 | 47.7 | % | $ | 207,123 | 47.4 | % | ||||||||||||
2008 | $ | 80,547 | 37.2 | % | $ | 95,937 | 39.6 | % | $ | 176,484 | 38.5 | % |
Gross margins in the AMS segment were 47.1% in 2009 and 37.2% in 2008. Gross profit in 2009 included purchase accounting adjustments of $597,000 as compared to $24.4 million in 2008. Ignoring the purchase accounting adjustments, gross margins were 47.4% in 2009 and 48.5% in 2008. The decrease in gross margins is principally attributable to decreased sales of components that generate higher margins, partially offset by increased sales of integrated circuit products combined with a favorable product mix in microelectronic modules and the acquisition of Gaisler in June 2008 ($3.0 million).
Gross margins in the ATS segment were 47.7% in 2009 and 39.6% in 2008. Gross profit in 2009 was negatively impacted by purchase accounting adjustments of $1.1 million versus $18.2 million in 2008. Ignoring the purchase accounting adjustments, gross margins were 48.1% in 2009 and 46.7% in 2008. Gross margins increased principally due to increased sales and margins in our wireless products and increased margins in our synthetic test products due to product mix, and are partially offset by lower margins due to a reduction in sales of frequency synthesizer products.
Selling, General and Administrative Costs. On a consolidated basis SG&A costs decreased 40 basis points as a percentage of sales from the nine months ended March 31, 2008 to the nine months ended March 31, 2009. Excluding merger related expenses ($3.6 million in 2009 and $4.6 million in 2008), stock compensation costs ($1.5 million in 2009 and $2.8 million in 2008), acquisition related depreciation expense ($884,000 in 2009 and $911,000 in 2008), restructuring costs ($463,000 in 2009 and $2.1 million in 2008) and a one-time lease termination cost ($576,000 in 2008), SG&A was $90.2 million in 2009 and $92.2 million in 2008.
Nine Months | Selling, General and Administrative Costs | |||||||||||||||||||||||||||
Ended | ||||||||||||||||||||||||||||
March 31, | % of | % of | % of | |||||||||||||||||||||||||
(In thousands) | AMS | sales | ATS | sales | Corporate | Total | sales | |||||||||||||||||||||
2009 | $ | 32,104 | 15.4 | % | $ | 49,835 | 21.8 | % | $ | 14,673 | $ | 96,612 | 22.1 | % | ||||||||||||||
2008 | $ | 31,543 | 14.6 | % | $ | 56,229 | 23.2 | % | $ | 15,409 | $ | 103,181 | 22.5 | % |
- 45 - -
In the AMS segment, selling, general and administrative costs increased $561,000, or 2%. As a percentage of sales, selling, general and administrative costs increased 80 basis points for AMS. Excluding restructuring costs ($260,000 in 2008), stock compensation costs ($56,000 in 2008), acquisition related depreciation expense ($29,000 in 2009 and $30,000 in 2008), SG&A was $32.1 million in 2009 and $31.2 million in 2008, representing an increase of 100 basis points as a percentage of sales for AMS.
In the ATS segment, selling, general and administrative costs decreased $6.4 million, or 11%, largely due to a $1.4 million reduction in restructuring costs and one time lease termination fees of $576,000 incurred in 2008 combined with cost savings related to the closing of our Burnham facility. As a percentage of sales, selling, general and administrative costs decreased 140 basis points for ATS. Excluding restructuring costs ($463,000 in 2009 and $1.8 million in 2008), a one-time lease termination cost of $576,000 in 2008, stock compensation costs ($90,000 favorable impact in 2008), acquisition related depreciation expense ($690,000 in 2009 and $744,000 in 2008), SG&A was $48.7 million in 2009 and $53.2 million in 2008.
Corporate general and administrative expenses decreased $736,000 primarily due to a reduction in stock-based compensation. As a percentage of sales, corporate general and administrative expenses remained relatively unchanged.
Research and Development Costs. On a consolidated basis, research and development expenses decreased 140 basis points as a percentage of sales.
Nine Months | Research and Development Costs | |||||||||||||||||||||||
Ended | ||||||||||||||||||||||||
March 31, | % of | % of | % of | |||||||||||||||||||||
(In thousands) | AMS | sales | ATS | sales | Total | sales | ||||||||||||||||||
2009 | $ | 22,178 | 10.6 | % | $ | 29,867 | 13.1 | % | $ | 52,045 | 11.9 | % | ||||||||||||
2008 | $ | 22,708 | 10.5 | % | $ | 38,026 | 15.7 | % | $ | 60,734 | 13.3 | % |
AMS segment self-funded research and development costs decreased $530,000, or 2%, primarily due to a reduction of microelectronic module projects, partially offset by increases in components projects and costs related to our acquisition of Gaisler ($588,000). As a percentage of sales, research and development costs increased 10 basis points.
ATS segment self-funded research and development costs decreased $8.2 million, or 21%, primarily due to (i) a reduction of $8.4 million in our wireless business relating to cost savings related to the closing of our Burnham facility and a reduction of wireless related projects and (ii) a reduction of $2.7 million in restructuring costs primarily in our wireless business partially offset by increased costs in our radio test products of $3.5 million.
Acquired In-Process Research and Development Costs. During the nine months ended March 31, 2008 and in connection with the Company Sale Transaction, we recorded and immediately expensed $24.3 million of acquired IPR&D costs ($15.7 million in the AMS segment and $8.6 million in the ATS segment). In 2009, we recorded and expensed $1.7 million of costs related to our acquisition of Gaisler in June 2008 and $626,000 of costs related to our acquisition of VI Technology in March 2009.
Restructuring Costs. The AMS segment incurred total restructuring costs of $402,000 ($107,000 in cost of sales, $260,000 in SG&A and $35,000 in R&D), in the nine months ended March 31, 2008 which relate to severance for personnel reductions within our Whippany, New Jersey components manufacturing facility.
- 46 - -
The ATS segment incurred restructuring costs of $2.8 million in the nine months ended March 31, 2009 ($2.0 million in cost of sales, $463,000 in SG&A and $303,000 in R&D). In comparison, in the nine months ended March 31, 2008, the ATS segment incurred restructuring costs of $5.2 million ($379,000 in cost of sales, $1.8 million in SG&A and $3.0 million in R&D). In both periods, the costs related to consolidation and reorganization efforts in our U.K. operations.
Amortization of Acquired Intangibles. Amortization of acquired intangibles decreased $6.4 million in 2009 primarily due to the impact of the change in foreign currency exchange rates, combined with the completion of amortization of acquired backlog recorded in the Merger. The amortization for the AMS segment decreased $3.8 million and the ATS segment decreased $2.6 million.
Company Sale Transaction Expenses. In the nine months ended March 31, 2008, we incurred Company Sale Transaction expenses of $36.2 million, consisting primarily of merger related change of control, severance and other compensation payments, a break-up fee and its related lawsuit settlement charge and legal and other professional fees. There were no comparable costs in the current period.
Other Income (Expense). Interest expense was $63.0 million in the nine months ended March 31, 2009 and $53.9 million in the nine months ended March 31, 2008. The increase is due to the addition of $870 million of debt to finance the purchase of the Company on August 15, 2007 combined with refinancing of our $225.0 million Senior Subordinated Unsecured Credit Facility, which increased the interest rate on the facility to 11.75%. Other income (expense) of $12.4 million for the nine months ended March 31, 2009 consisted primarily of $10.5 million of foreign currency transaction gains and $1.3 million of interest income. Other income (expense) of $4.2 million for the nine months ended March 31, 2008 consisted primarily of $2.0 million of foreign currency transaction gains and $1.6 million of interest income.
Provision for Income Taxes. The income tax benefit was $17.3 million for the nine months ended March 31, 2009, an effective income tax rate of 41.2%. We had an income tax benefit for the nine months ended March 31, 2008 of $43.2 million, an effective income tax rate of 28.5%. The effective income tax rate for the two periods differed from the amount computed by applying the U.S. Federal income tax rate to income before income taxes primarily due to foreign, state and local income taxes and, for 2008, the tax benefit was decreased for the impact of certain Company Sale Transaction expenses that were not deductible for tax purposes, as well as nondeductible IPR&D. We paid income taxes of $3.0 million in the nine months ended March 31, 2009 and $7.3 million in the nine months ended March 31, 2008.
Income (loss) from Continuing Operations. The loss from continuing operations was $24.7 million for the nine months ended March 31, 2009 and $108.4 million for the nine months ended March 31, 2008.
Liquidity and Capital Resources
As of March 31, 2009, we had $53.9 million of cash and cash equivalents, $200.3 million in working capital and our current ratio was 2.4 to 1. As of June 30, 2008, we had $54.1 million of cash and cash equivalents, $220.9 million in working capital and our current ratio was 2.4 to 1.
At March 31, 2009, our marketable securities consisted of $17.5 million of auction rate securities, net of a $2.4 million valuation allowance, discussed below. Auction rate securities represent long-term (generally maturities of ten years to thirty-five years from the date of issuance) variable rate bonds tied to short-term interest rates that are reset through an auction process, which occurs every seven to thirty-five days, and are classified as available for sale securities. All but one (with the one security having a carrying value of $1.6 million and an A rating) of our auction rate securities retain a triple-A rating by at least one nationally recognized statistical rating organization. In addition, certain of our auction rate securities are backed by student loans whose principal and interest are federally guaranteed by the Family Federal Education Loan Program. We have redeemed $26.5 million of auction rate securities at par since February 8, 2008.
- 47 - -
Given the high credit quality of our auction rate securities and our intent and ability to hold these securities until liquidity returns to the market or maturity, if necessary, we believe we will recover the full principal amount of $19.9 million, in the future. However, at March 31, 2009, we estimated that the fair value of our auction rate securities was $17.5 million. Since many auctions are failing and given that there is currently no active secondary market for our investment in auction rate securities, the determination of fair value was based on the following:
· | continuing illiquidity; |
· | lack of action by the issuers to establish different forms of financing to replace or redeem these securities; and |
· | the credit quality of the underlying securities. |
Should credit market disruptions continue or increase in magnitude, we may be required to record a further impairment on our investments or consider that an ultimate liquidity event may take longer than currently anticipated.
Auction rate securities are classified as non-current assets in the accompanying March 31, 2009 and June 30, 2008 consolidated balance sheets.
Our principal liquidity requirements are to service our debt and interest and meet our working capital and capital expenditure needs. As of March 31, 2009, we had $886.6 million of debt outstanding (of which $881.2 million was long-term), including approximately $516.9 million under our senior secured credit facility, $225.0 million of unsecured senior notes and $143.3 million under our senior subordinated unsecured credit facility, including paid-in-kind interest. Additionally, at March 31, 2009 we were able to borrow an additional $50.0 million under the revolving portion of our senior secured credit facility.
The following is a summary of required principal repayments of long-term debt for the next five years and thereafter as of March 31, 2009:
Twelve months ended March 31, | (In thousands) | |||
2010 | $ | 5,383 | ||
2011 | 5,590 | |||
2012 | 5,610 | |||
2013 | 5,635 | |||
2014 | 5,250 | |||
Thereafter | 859,128 | |||
Total | $ | 886,596 |
We expect that cash generated from operating activities and availability under the revolving portion of the senior secured credit facility will be our principal sources of liquidity. Our ability to make payments on and to refinance our indebtedness and to fund working capital needs and planned capital expenditures will depend on our ability to generate cash in the future. This, to a certain extent, is subject to general economic, financial, competitive and other factors that are beyond our control. Based on our current level of operations, we believe our cash flow from operations and available borrowings under our senior secured credit facility will be adequate to meet our liquidity needs for at least the next twelve months. We cannot assure you, however, that our business will generate sufficient cash flow from operations, or those future borrowings will be available to us under our senior secured credit facility in an amount sufficient to enable us to repay our indebtedness or to fund other liquidity needs. We may need to refinance all or a portion of our indebtedness on or before the maturity thereof. We cannot assure you that we will be able to refinance any of our indebtedness on commercially reasonable terms or at all.
- 48 - -
Cash Flows
For the nine months ended March 31, 2009, our cash flow provided by continuing operations was $35.0 million. Our investing activities from continuing operations used cash of $19.4 million, primarily for $13.0 million of capital expenditures and $7.8 million of payments for purchase of businesses (net of cash acquired). Our financing activities used cash of $4.5 million, primarily to repay $4.1 million of debt.
For the nine months ended March 31, 2008, our cash flow used in continuing operations was $14.9 million. Our investing activities from continuing operations used cash of $1.1 billion, primarily for payments of $1.1 billion to predecessor shareholders and option holders, net of cash acquired, $9.6 million of capital expenditures and the purchase (net of sales) of marketable securities of $22.3 million. Our financing activities provided cash of $1.2 billion, primarily from borrowings under our credit facilities of $870.0 million on August 15, 2007 and proceeds from the issuance of common stock of $378.4 million, also on August 15, 2007.
Capital Expenditures
Capital expenditures were $13.0 million and $9.6 for the nine months ended March 31, 2009 and 2008, respectively. Our capital expenditures primarily consist of equipment replacements.
Contractual Obligations
The following table summarizes our obligations and commitments to make future payments under debt, and other obligations as of March 31, 2009:
Payments Due By Period (1) | ||||||||||||||||||||
(In millions) | ||||||||||||||||||||
Less Than | After | |||||||||||||||||||
Total | 1 Year | 1 - 3 Years | 4 - 5 Years | 5 Years | ||||||||||||||||
Senior secured credit facility | $ | 516.9 | $ | 5.1 | $ | 10.5 | $ | 10.5 | $ | 490.8 | ||||||||||
Senior unsecured notes | 225.0 | - | - | - | 225.0 | |||||||||||||||
Subordinated unsecured credit facility | 143.3 | - | - | - | 143.3 | |||||||||||||||
Other long-term debt | 1.4 | 0.3 | 0.7 | 0.4 | - | |||||||||||||||
Operating leases (2) | 19.6 | 6.0 | 8.4 | 3.6 | 1.6 | |||||||||||||||
Employment agreements | 9.2 | 3.7 | 4.5 | 1.0 | - | |||||||||||||||
Advisory fee (3) | 10.2 | 2.2 | 4.3 | 3.7 | - | |||||||||||||||
Total | $ | 925.6 | $ | 17.3 | $ | 28.4 | $ | 19.2 | $ | 860.7 |
(1) | Amounts do not include interest payments. |
(2) | The Company does not expect any future minimum sub-lease rentals associated with operating lease commitments shown in the above table. |
(3) | The annual advisory fee is payable to our Sponsors throughout the term of an advisory agreement, which has an initial term expiring on December 31, 2013 and is automatically renewable for additional one year terms thereafter unless terminated. For purposes of this table we have assumed that such agreement terminates December 31, 2013. The annual fee will be the greater of $2.2 million or 1.8% of adjusted EBITDA for the prior fiscal year, as defined in the agreement. |
- 49 - -
In the normal course of business, we routinely enter into binding and non-binding purchase obligations primarily covering anticipated purchases of inventory and equipment. None of these obligations are individually significant. We do not expect that these commitments, as of March 31, 2009, will have a material adverse affect on our liquidity.
Off-Balance Sheet Arrangements
We do not maintain any off-balance sheet arrangements, transactions, obligations or other relationships with unconsolidated entities that would be expected to have material current or future effect upon our financial condition or results of operations.
Seasonality
Historically our net sales and earnings increase sequentially from quarter to quarter within a fiscal year, but the first quarter is typically less than the previous year’s fourth quarter.
Accounting Policies Involving Significant Estimates
The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the revenues and expenses during the period reported. The following accounting policies require us to make estimates and assumptions based on the circumstances, information available and our experience and judgment. These estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the period that they are determined to be necessary. If actual results differ significantly from our estimates, our financial statements could be materially impacted.
Revenues and Cost Recognition. We recognize revenue when persuasive evidence of an arrangement exists, the selling price is fixed or determinable, and collectability of the resulting receivable is reasonably assured.
For arrangements other than certain long-term contracts, revenue (including shipping and handling fees) is recognized when products are shipped and title has passed to the customer. If title does not pass until the product reaches the customer’s delivery site, recognition of the revenue is deferred until that time. Certain of our sales are to distributors which have a right to return some portion of product within up to eighteen months of sale. We recognize revenue on these sales at the time of shipment to the distributor as the returns under these arrangements have been insignificant and can be reasonably estimated. A provision for such estimated returns is recorded at the time sales are recognized.
Long-term contracts are accounted for in accordance with SOP 81-1 “Accounting for Performance of Construction-Type and Certain Production-Type Contracts.” We determine estimated contract profit rates and use the percentage-of-completion method to recognize revenues and associated costs as work progresses on certain long-term contracts. We measure the extent of progress toward completion generally based upon one of the following methods (based upon an assessment of which method most closely aligns to the underlying earnings process), (i) the units-of-delivery method, (ii) the cost-to-cost method, using the ratio of contract costs incurred as a percentage of total estimated costs at contract completion (based upon engineering and production estimates), or (iii) the achievement of contractual milestones. Provisions for anticipated losses or revisions in estimated profits on contracts-in-process are recorded in the period in which such anticipated losses or revisions become evident.
Revenue from sales of products where software is other than incidental to their performance, including related software support and maintenance contracts is recognized in accordance with SOP-97-2, “Software Revenue Recognition.” Accordingly, revenue for software is recognized when the software is delivered, provided the requisite criteria for revenue recognition are met.
- 50 - -
When a customer purchases software together with post contract support, we allocate a portion of the fee to the post contract support for its fair value based on the contractual renewal rate or the amount the support is sold for on a standalone basis. Post contract support fees are deferred in Advance Payments by Customers and Deferred Revenue and recognized as revenue ratably over the term of the related contract.
Inventories. Inventories are valued at the lower of cost (first-in, first-out) or market. Inventory levels are maintained in relation to expected sales volumes. We periodically evaluate the net realizable value of our inventory. Numerous analyses are applied including lower of cost or market analysis, forecasted sales requirements and forecasted warranty requirements. After taking these and other factors into consideration, such as technological changes, age and physical condition, appropriate adjustments are recorded to the inventory balance. If actual conditions differ from our expectation, then inventory balances may be over or under valued, which could have a material effect on our results of operations and financial condition.
Purchase Accounting and Recoverability of Long-Lived and Intangible Assets. Determining the fair value of certain assets and liabilities acquired in a business combination is judgmental in nature and often involves the use of significant estimates and assumptions. There are various methods used to estimate the value of tangible and intangible assets acquired, such as discounted cash flow and market multiple approaches. Some of the more significant estimates and assumptions inherent in the two approaches include: projected future cash flows (including timing); discount rate reflecting the risk inherent in the future cash flows; perpetual growth rate; determination of appropriate market comparables; and the determination of whether a premium or a discount should be applied to comparables. There are also judgments made to determine the expected useful lives assigned to each class of assets and liabilities acquired. Goodwill is measured as the excess of the cost of acquisition over the sum of the amounts assigned to identifiable assets acquired less liabilities assumed. We perform an assessment of whether there is an indication that goodwill is impaired on an annual basis unless events or circumstances warrant a more frequent assessment. The impairment assessment involves, among other things, an estimation of the fair value of each of our reporting units. We engage an independent valuation expert using both a market value approach, when applicable and an income based approach to assist us in estimating those fair values. Such estimates are inherently subjective, and subject to change in future periods.
In response to changes in industry and market conditions, we could be required to strategically realign our resources and consider restructuring, disposing of, or otherwise exiting businesses, which could result in the impairment of goodwill and other long lived assets, as well as a reduction in the useful lives of such depreciable or amortizable long lived assets. Impairment charges and the reduction in useful lives could have a material impact on our results of operations and financial condition.
Property, plant and equipment are stated at cost less accumulated depreciation computed on a straight-line basis over the estimated useful lives of the related assets. Leasehold improvements are amortized over the life of the lease or the estimated life of the asset, whichever is shorter. Changes in circumstances such as technological advances or changes to our business model can result in the actual useful lives differing from our estimates. To the extent the estimated useful lives are incorrect, the value of these assets may be over or under stated, which in turn could have a material effect on our results of operations and financial condition.
Long-lived assets other than goodwill are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of any such asset may be impaired. We evaluate the recoverability of such assets by estimating future cash flows. If the sum of the undiscounted cash flows expected to result from the use of the assets and their eventual disposition is less than the carrying amount of the assets, we will recognize an impairment loss to the extent of the excess of the carrying amount of the assets over the discounted cash flows.
- 51 - -
If our actual results are not as favorable as the forecasted results used in our impairment reviews of goodwill and other long-lived assets, impairment charges may be necessary which could have a material effect on our results of operations and financial condition.
Restructuring Charges. When we incur a liability related to a restructuring charge, we estimate and record all appropriate expenses. These expenses include severance, retention bonuses, fringe benefits, asset impairment, buyout of leases and inventory write-downs. To the extent that our estimates differ from actual expenses, there could be significant additional expenses or reversals of previously recorded charges in the future.
Income Taxes. Significant judgment is required in determining our worldwide income tax provision. In the ordinary course of a global business, there are many transactions and calculations where the ultimate tax outcome is uncertain. Some of these uncertainties arise as a consequence of revenue sharing and cost reimbursement arrangements among related entities, the process of identifying items of revenues and expense that qualify for preferential tax treatment and segregation of foreign and domestic income and expense to avoid double taxation. No assurance can be given that the final tax outcome of these matters will not be different than that which is reflected in our historical income tax provisions and accruals. Such differences could have a material effect on our income tax provision and net earnings in the period in which such determination is made.
We record a valuation allowance to reduce our deferred tax assets to the amount of future tax benefit that is more likely than not to be realized. While we have considered future taxable income and ongoing prudent and feasible tax planning strategies in assessing the need for the valuation allowance, there is no assurance that sufficient taxable income will be generated in future years or that tax strategies will continue to be prudent. Accordingly, the valuation allowance might need to be increased to cover additional deferred tax assets that may not be realizable. Any increase in the valuation allowance could have a material adverse impact on our income tax provision and net earnings in the period in which such determination is made.
Share-Based Compensation. We are required to record the fair value of share based compensation awards as an expense. In order to determine the fair value of stock options on the date of grant, the Company utilizes the Black-Scholes option-pricing model. Inherent in this model are assumptions related to expected stock price volatility, option life, risk-free interest rate and dividend yield. Expected volatilities are based on historical volatility of our shares using daily price observations over a period consistent with the expected life. We used the safe harbor guidance in Staff Accounting Bulletin (“SAB”) 107 to estimate the expected life of options granted during fiscal 2007 and 2006. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods similar to the expected life. While the risk-free interest rate and dividend yield are less subjective assumptions, typically based on factual data derived from public sources, the expected stock price volatility and option life assumptions require a greater level of judgment which makes them critical accounting estimates.
Recently Adopted Accounting Pronouncements
See Note 1 of the condensed consolidated financial statements.
Recently Issued Accounting Pronouncements Not Yet Adopted
See Note 1 of the condensed consolidated financial statements.
- 52 - -
Forward-Looking Statements
All statements other than statements of historical fact included in this Quarterly Report, including without limitation statements under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding our financial position, business strategy and plans and objectives of our management for future operations, are forward-looking statements. When used in this Quarterly Report, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or our management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of our management, as well as assumptions made by and information currently available to our management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, including but not limited to those set forth above. Such statements reflect our current views with respect to the future and are subject to these and other risks, uncertainties and assumptions relating to our financial condition, results of operation, growth strategy and liquidity. We do not undertake any obligation to update such forward-looking statements.
ITEM 3 – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Interest Rate Risk. We are subject to interest rate risk in connection with borrowings under our senior secured credit facility. Although we currently have interest rate swap agreements hedging portions of this debt, these will expire before the borrowings are fully repaid. As of March 31, 2009, we have $517 million outstanding under the term-loan portion of our senior secured credit facility, some of which is subject to variable interest rates. Each change of 0.125% in interest rates would result in a $58,000 change in our annual interest expense on the un-hedged portion of the term-loan borrowings and a $63,000 change in our annual interest expense on the revolving loan borrowings, assuming the entire $50.0 million was outstanding. Any debt we incur in the future may also bear interest at floating rates.
Foreign Currency Risk. Foreign currency contracts are used in certain circumstances to protect us from fluctuations in exchange rates. We enter into foreign currency contracts, which are not designated as hedges. Thus the change in fair value is included in income as it occurs, within other income (expense). As of March 31, 2009, we had $10.7 million of notional value foreign currency forward contracts maturing through June 2009. Notional amounts do not quantify risk or represent assets or liabilities of the Company, but are used in the calculation of cash settlements under the contracts. The fair value of these contracts was a $33,000 liability at March 31, 2009 and a $13,000 asset at June 30, 2008. If foreign currency exchange rates (primarily the British pound and the Euro) change by 10% from the levels at March 31, 2009, the effect on our comprehensive income would be approximately $20.5 million.
Inflation Risk. Inflation has not had a material impact on our results of operations or financial condition during the preceding three years.
ITEM 4T – CONTROLS AND PROCEDURES
Our disclosure controls and procedures under the Securities Exchange Act of 1934, as amended, are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the Securities and Exchange Commission. The Principal Executive Officer and the Principal Financial Officer, with the assistance from other members of management, have reviewed the effectiveness of our disclosure controls and procedures as of March 31, 2009 and, based on their evaluation, have concluded that the disclosure controls and procedures were effective as of such date.
There have been no changes in our internal controls over financial reporting that occurred during the quarter ended March 31, 2009 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
- 53 - -
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
In March 2005, we sold the net assets of our shock and vibration control device manufacturing business (“VMC”). Under the terms of the sale agreements, we retained certain liabilities relating to adverse environmental conditions that existed at the premises occupied by VMC as of the date of sale. We recorded a liability for the estimated remediation costs related to adverse environmental conditions that existed at the VMC premises when it was sold. The accrued environmental liability at March 31, 2009 is $1.0 million, of which $322,000 is expected to be paid within one year.
During the quarter ended March 31, 2007, we became aware that certain RadHard bidirectional multipurpose transceivers sold by us since 1999 may have been subject to the licensing jurisdiction of the U.S. Department of State in accordance with the International Traffic in Arms Regulations (“ITAR”). Accordingly, we filed a Voluntary Disclosure with the Directorate of Defense Trade Controls, Department of State, describing the details of the possible inadvertent misclassification. Simultaneously, we filed a Commodity Jurisdiction request providing detailed information and data supporting our contention that the product is not subject to ITAR and requesting a determination that such product is not ITAR controlled. By letter dated November 15, 2007, we were informed that the U.S. Department of State had determined in response to our Commodity Jurisdiction request, that the product is subject to the licensing jurisdiction of the U.S. Department of State in accordance with ITAR. We requested reconsideration of this determination. On February 7, 2008, we filed an addendum to the above referenced Voluntary Disclosure advising the Directorate of Defense Trade Controls that other products sold by us similar in nature to the transceiver described above may also be subject to the ITAR. The Directorate of Defense Trade Controls agreed to extend our time to file such addendum to the Voluntary Disclosure until a decision was rendered with respect to our request for reconsideration of the determination in connection with the above-referenced Commodity Jurisdiction request. On August 5, 2008, we received a letter from the Office of Defense Trade Controls Compliance (“DTCC”) requesting that we provide documentation and/or information relating to our compliance initiatives after November 15, 2007 as well as the results of any product reviews conducted by us, and indicating that a civil penalty against us could be warranted in connection with this matter following the review of such materials. We have provided all of the materials and documentation requested by the DTCC. Our request for reconsideration was denied by the Directorate of Defense Trade Controls on August 19, 2008 which determined that the product is subject to the licensing jurisdiction of the Department of State in accordance with ITAR. Accordingly, on September 18, 2008, we filed an addendum to our Voluntary Disclosure identifying other products that may have been subject to the licensing jurisdiction of the U.S. Department of State in accordance with the ITAR but were inadvertently misclassified. At this time it is not possible to determine whether any fines or other penalties will be asserted against us, or the materiality of any outcome.
During May 2008, we became further aware that a certain product sold by our KDI subsidiary may have inadvertently been misclassified as not ITAR controlled. On August 5, 2008, we filed a Voluntary Disclosure with the Directorate of Defense Trade Controls, Department of State, describing the inadvertent misclassification of this product. In January 2009 we identified another product that should have been included in the August 5, 2008 disclosure. We filed an initial disclosure with the Department of State identifying this product, and the Department of State instructed us to file an amendment to the August 5, 2008 disclosure. That amendment was filed in April 2009. At this time it is not possible to determine whether any fines or other penalties will be asserted against us with respect to the foregoing matters, or the materiality of any outcome.
During November 2008, we became aware that our Hauppauge facility had shipped two ITAR controlled products to a foreign customer, but inadvertently had noted on the requisite paperwork that only one ITAR controlled product was included in the shipment. We filed a voluntary disclosure in January 2009, and that disclosure has been closed by the State Department and no fine or penalty was assessed.
- 54 - -
During January 2009, we became aware that a certain product sold by our Powell subsidiary, for which an ITAR marketing license had been properly issued by the U.S. Department of State, mistakenly was taken out of the country by an employee without first obtaining the required U.S. Customs signature upon departure. We have filed an initial disclosure relating to this issue and will file a detailed disclosure by June 6, 2009. At this time it is not possible to determine whether any fines or other penalties will be asserted against us, or the materiality of any outcome.
In the third quarter of fiscal 2009, we became aware that a product sold and licensed to Raytheon U.K. was actually forwarded to an end user in Saudi Arabia. Aeroflex did not identify that end user on the initial license application, so the product in question was forwarded to Saudi Arabia when it was only authorized to travel as far as the U.K. We filed an initial disclosure concerning this matter in April 2009. At this time it is not possible to determine whether any fines or penalties will be asserted against us, or the materiality of any outcome.
In March 2009 we became aware that Aeroflex’s subsidiary, Micrometrics, had inadvertently misclassified a component and shipped it to a foreign customer in Italy under the jurisdiction of the Export Administration Regulations ("EAR") when it should have been shipped under the jurisdiction of the ITAR. We filed an initial voluntary disclosure concerning this matter in April 2009. At this time it is not possible to determine whether any fines or penalties will be asserted against us, or the materiality of any outcome.
An amended class action complaint was filed against us and the Predecessor Entity’s board of directors on June 20, 2007 in the Supreme Court of the State of New York, Nassau County. The complaint alleges that the board breached its fiduciary duties to our stockholders (i) by issuing a preliminary proxy statement on June 5, 2007 that was issued in connection with seeking stockholder approval of the Merger and (ii) in approving certain amendments, that were allegedly beyond the scope of our corporate powers, to our SERP and the employment agreements of defendants Harvey R. Blau, our then Chairman and Chief Executive Officer, and Leonard Borow, our then President and Chief Operating Officer and currently, the Successor Entity’s President and Chief Executive Officer. We are currently in settlement discussions with the plaintiffs and have accrued an insignificant liability for the settlement.
We are also involved in various other claims and legal actions that arise in the ordinary course of business. We do not believe that the ultimate resolution of any of these actions will have a material adverse effect on our financial position, results of operations, liquidity or capital resources.
Item 1A. Risk Factors
There have been no material changes in our risk factors from the risk factors disclosed in the Registration Statement on Form S-1 filed on February 2, 2009, and which became effective on February 11, 2009.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None
Item 3. Defaults upon Senior Securities
None
Item 4. Submission of Matters to a Vote of Security Holders
None
- 55 - -
Item 5. Other Information
None
Item 6. Exhibits
Exhibit No. | Exhibit Description | |
31.1 | Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
31.2 | Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
31.3 | Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
32.1 | Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
32.2 | Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
- 56 - -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
AEROFLEX INCORPORATED | ||
(REGISTRANT) | ||
May 14, 2009 | /s/ John Adamovich, Jr. | |
John Adamovich, Jr. | ||
Sr. Vice President and | ||
Chief Financial Officer |
- 57 - -
EXHIBIT INDEX
Exhibit No. | Exhibit Description | |
31.1 | Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
31.2 | Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
31.3 | Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
32.1 | Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
32.2 | Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
- 58 - -
Exhibit 31.1
CERTIFICATION
I, Leonard Borow, President and Chief Executive Officer of Aeroflex Incorporated, certify that:
1. | I have reviewed this quarterly report on Form 10-Q for the quarter ended March 31, 2009 of Aeroflex Incorporated; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: | May 14, 2009 | /s/ Leonard Borow | |
Leonard Borow | |||
President and Chief Executive Officer |
Exhibit 31.2
CERTIFICATION
I, John Adamovich, Jr., Chief Financial Officer of Aeroflex Incorporated, certify that:
1. | I have reviewed this quarterly report on Form 10-Q for the quarter ended March 31, 2009 of Aeroflex Incorporated; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: | May 14, 2009 | /s/ John Adamovich, Jr. | |
John Adamovich, Jr. | |||
Sr. Vice President and | |||
Chief Financial Officer |
Exhibit 31.3
CERTIFICATION
I, Charles Badlato, Principal Accounting Officer of Aeroflex Incorporated, certify that:
1. | I have reviewed this quarterly report on Form 10-Q for the quarter ended March 31, 2009 of Aeroflex Incorporated; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: | May 14, 2009 | /s/ Charles Badlato | |
Charles Badlato | |||
Principal Accounting Officer |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Leonard Borow, President and Chief Executive Officer of Aeroflex Incorporated, hereby certify that the Form 10-Q of Aeroflex Incorporated for the period ended March 31, 2009 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Aeroflex Incorporated.
/s/ Leonard Borow |
Name: Leonard Borow |
Date: May 14, 2009 |
A signed original of this written statement required by Section 906 has been provided to Aeroflex Incorporated and will be retained by Aeroflex Incorporated and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, John Adamovich, Jr., Chief Financial Officer of Aeroflex Incorporated, hereby certify that the Form 10-Q of Aeroflex Incorporated for the period ended March 31, 2009 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Aeroflex Incorporated.
/s/ John Adamovich, Jr. |
Name: John Adamovich, Jr. |
Date: May 14, 2009 |
A signed original of this written statement required by Section 906 has been provided to Aeroflex Incorporated and will be retained by Aeroflex Incorporated and furnished to the Securities and Exchange Commission or its staff upon request.